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ABSTRACT 
 
 
 The principal goal in this project is to determine if a one-dimensional diode array, the 
Profiler (Sun Nuclear Corporation), can be used as a tool for intensity modulated radiation 
therapy qua lity assurance (QA). A one-dimensional diode array can be used to measure dose 
and dose profiles for IMRT fields. 
  IMRT fields for real cases at Mary Bird Perkins Cancer Center were used to test the 
Profiler model 1170 (Sun Nuclear Corporation). The main concern with the Profiler is that 
there is not central diode in the array. The absorbed dose displayed in the Profiler window is 
the average of the absorbed dose measured by the two central diodes.  Absorbed dose 
measured using the Profiler was compared with absorbed dose measured using an ion 
chamber.  The dose profiles obtained with the Profiler were also compared to those obtained 
by film dosimetry. The dose measured with the Profiler was within 5% regard to the dose 
measured using ion chamber. The quality of the profiles obtained with the Profiler were 
similar to those obtained using film dosimetry 
 The Profiler demonstrated to be feasible as a QA instrument for IMRT cases. 
Therefore, one-dimensional diode array can definitely be used as a tool for IMRT QA. 
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CHAPTER 1 
 
INTRODUCTION 
 
 
 Over the years, it has been well-known that the main goal of the battle against 
cancer is to deliver enough dose of radiation to the tumor while sparing critical organs or 
healthy tissue. Various irradiation techniques and treatment planning techniques have 
been designed to find the right balance between tumor control and injury to normal 
tissue. The problem to face is that certain tumors are in very complex three-dimensional 
shapes. Further, some of them are wrapped by critical organs which need to be protected.  
One recent technology designed to overcome this kind of complex volume target is 
Intensity Modulated Radiation Therapy (IMRT).  Improved control over the dose 
delivered is offered by this technology by means of a computer-controlled multi- leaf  
collimator  (MLC). With IMRT, unlimited three-dimensional shapes can be used to 
deliver a prescribed dose to the target. 
 Mary Bird Perkins Cancer Center (MBPCC) is one of many centers that treat their 
patients by using this relative new technology. Of course, this new technology requires 
special quality assurance procedures to be applied to the patients.  Every IMRT treatment 
has a verification procedure of the planned IMRT fields to confirm the reliability of the 
plan to be delivered [1].  
 Mary Bird Perkins Cancer Center currently uses film dosimetry to perform the 
quality assurance required for each patient treated with IMRT fields. Every single IMRT 
field, ranging between 5 and 9 fields per patient, is performed in a phantom to verify if 
the MLC are moving as directed by the plan calculated by ADAC algorithm. The 
delivered dose measured by using film dosimetry is compared to the dose calculated by 
2 
the ADAC algorithm [2, 3]. A maximum difference of 5% between the absorbed dose 
measured by film dosimetry and the dose calculated by ADAC algorithm is the 
established limit to accept the IMRT treatment plan to be delivered to the patient. 
 However, some verification of patient-specific IMRT fields result in differences 
greater than 5%. When this happens, film dosimetry is repeated.  If the result is within 
5% limit, the plan is accepted; otherwise, the plan is recalculated. 
 The following examples are real cases in MBPCC that needed their IMRT QA to 
be repeated because the first attempt had differences greater than 5% when compared 
with results given by the ADAC algorithm.  
 
 
 
    
March 19, 2003 
  
March 20, 2003 
  
March 24, 2003 
  
Fields 
 
Expected 
Dose (cGy) 
Measured 
Dose (cGy) 
% Diff 
 
Measured  
Dose (cGy) 
% Diff 
 
Measured 
Dose (cGy) 
% Diff 
 
A 29.86 24.38 -18.35 27.06 -9.38 29.54 -1.07 
B 30.00 25.12 -16.27 28.13 -6.23 28.29 -5.70 
C 29.74 25.51 -14.22 27.09 -8.91 28.00 -5.85 
D 30.15 26.71 -11.41 28.27 -6.24 29.47 -2.26 
E 29.89 26.67 -10.77     28.05 -6.16 
F 30.02 26.17 -12.82     28.39 -5.43 
G 29.98 30.94 3.20     30.65 2.23 
H 30.19 26.85 -11.06     28.70 -4.94 
 
 
 
 
Table 1.1 Measured dose in IMRT fields for case 1.   
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    April 10, 2003   April 15, 2003   
fields 
Expected Dose 
(cGy) 
Measured 
Dose (cGy) 
% Diff 
 
Measured 
Dose (cGY) 
% Diff 
 
A 29.99 27.44 -8.50 29.01 -3.27 
B 30.75 27.98 -9.01 30.21 -1.76 
C 30.13 26.20 -13.04 30.12 -0.03 
D 30.25 27.20 -10.08 29.86 -1.29 
E 29.96 27.35 -8.71 28.96 -3.34 
F 30.01 27.00 -10.03 29.67 -1.13 
 
 As Tables 1.1 and 1.2 show, measured dose was not the expected dose when 
measured in the first attempt. IMRT QA had to be repeated. It is common to find a case 
where one, two or three fields have differences greater than 5% when compared with 
calculation made by ADAC.  The question is what is the cause of the discrepancy? There 
are some potential error sources. For instance, film dosimetry process [4], inaccuracy in 
the Linac and/or multi- leaf controls [5], inaccuracy in the dose calculation algorithm [4] or 
mistakes made by the physicist when performing the IMRT QA, might be some error 
sources. These uncertainties can be introduced when performing quality assurance but by 
repeating the QA using the same instrument of measurement (film dosimetry) we are 
only expressing that the error was made by the physicist.  Of course, it can be possible. 
However, we are not ruling out the others potential error sources.   
Having an alternative way to measure the dose profiles and the absorbed dose at 
selected point s in the IMRT fields allows instrument errors to be ruled out or detected. In 
other words, if the differences between the absorbed dose calculated by ADAC and the 
absorbed dose measured by using two different instrument are still the same,  the error is 
Table 1.2  Measured dose in IMRT fields  for case 2.   
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likely due to neither physicist’s mistakes nor defects in the instruments.  The errors are, 
most likely, a consequence of uncertainty in the Clinac radiation delivery, the multi- leaf 
controls or inaccuracy in the data base that feeds ADAC algorithm. 
 On the other hand, if the differences between doses measured by using both 
instruments are different when compared with dose calculated by ADAC algorithm, we 
can obviously suspect the QA instrument that has been used. 
 One alternative instrument to measure dose and dose profiles in IMRT QA is a 
one-dimensional diode array.  MBPCC owns one, the Profiler, model 1170 designed by 
Sun Nuclear Corporation. There are reasons to believe that the Profiler model 1170 might 
be useful for IMRT QA 
 The Profiler has been specifically designed to test beam flatness and symmetry, 
dynamic wedges and other beam tests with regular collimation.  However, Sun Nuclear 
Corporation has recently improved this instrument with enhanced detectors that are the 
same type as used in Mapcheck. Mapcheck  is a two dimensional diodes array designed 
specifically for efficient IMRT plan QA. It has been also designed by Sun Nuclear 
Corporation. 
 Literature has been published where the Profiler has been used to collect data 
delivered by IMRT using multi- leaf collimation [1, 6].  
 Additionally, some third-party vendors openly express in their catalogues that the 
Profiler can be used to compare multi- leaf collimator profiles [7]. 
  An alternative instrument to measure absorbed dose and dose profiles given by 
IMRT fields provides significant improvement in the process of quality assurance for 
IMRT at Mary Bird Perkins.  However, one must carefully evaluate the profiler’s 
5 
performance to ensure that it can be used appropriate for IMRT QA purposes. Therefore, 
the main objective of this thesis is to determine if the Profiler can be used as a tool for 
IMRT QA. 
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CHAPTER 2 
  
 REVIEW OF LITERATURE 
 
Intensity Modulated Radiation Therapy (IMRT) is a new modality to treat patients 
with tumors located near to critical organs.  This new treatment is made possible due to 
the incorporation of multi- leaf (MLC) technology in clinacs. By using IMRT in treatment 
deliveries, it is possible to produce modulated fluence distribution and consequently to 
have intricate isodose distribution which could be impossible to have with conventional 
3-D conformal therapy.  This technique creates a 3D surface dose distribution so that it 
can have the shape of the target volume. Therefore, most of the tumor can be treated 
while sparing sensitive tissue around it. 
The beam intensities are adjusted by computational approach tha t is optimization 
algorithm. As a result, dose distributions that maximize the desired plan can be obtained. 
A modulated fluence distribution is generated by the inverse treatment planning system 
which is transferred to a leaf sequence algorithm (“leaf sequencer”).  The trajectories of 
pair of MLC leaves are then calculated by the sequencer to create the required fluence 
profiles.  The multi- leaf collimator is used to block the radiation to produce the 
modulated patterns. The transmission through the leaf is also accounted when 
determining the leaf trajectories. 
 Two modalities can be used to deliver the treatment planning: dynamic MLC and 
segmental methods. The modality used in Mary Bird Perkins Cancer Center is the 
segmental methods which is also called “s tep and shoot”. In this modality the leaf-end is 
stopped by the multi- leaf controller to set the first gap before radiation is initiated and 
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then a signal is given to the clinac controller  to shoot a burst of radiation though the gap. 
After that, the clinac is temporality stops producing X-rays while the leaves are moved by 
the MLC controller to the next gap. Another burst of radiation is produced after the MLC 
controller determines that the leaves are already in the specific position. This sequence is 
repeated until the complete intensity pattern is delivered [8].  
 The preliminary step to IMRT treatment is to acquire data from the patient in the 
exact position to be treated by using a CT scanner. A 3-D imaging of anatomical 
geometry of the patient can be constructed. 
 This anatomy information obtained by CT is used by the physician and 
dosimetrist to identity the tumor and other areas to be treated. The normal tissue that 
needs to be avoided during the treatment delivery is recognized as well. Using a 
specialized software (ADAC), beams arrangement is proposed to find the optimal plan. 
The process of selecting the inverse treatment planning is very computational intensive 
[9].  
 After the plan is approved by physicians, it is ready to be delivered to the patient. 
However, before delivering, a special quality assurance procedure is required to insure 
that the patient is treated in an accurate, efficient and safe manner. 
 The same beams to be used for the treatment in the patient are used to compute 
the dose distribution in a quality assurance phantom. The plan is applied to the phantom 
which has been previously scanned to obtain its geometrical shape and internal 
components. Some spot in the phantom dose distribution are selected and the dose is 
calculated there. This dose, now, is verified by using film dosimetry.  The film is placed 
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in the phantom so that a two dimensional dose distribution containing the spot previously 
chosen can be obtained. 
 By applying the same beams to the phantom and using ADAC computer 
algorithm to calculate the dose distribution in the phantom, a dose )',','( zyxD phantom , 
where  )',','( zyx are the coordinates  of the corresponding point in the phantom system, 
can be obtained. Measurements of the phantom plan give the measured dose                   
)',','( zyxM phantom. If the dose calculation performed by ADAC for both the patient and 
the phantom plan and beam delivered are performed accurately, the following relation 
should stand, 
1
)',','(
)',','(
),,(
),,(
===
phantom
phantom
patient
patient
zyxAD
zyxM
zyxAD
zyxED
ADACDose
seExpectedDo
        (2.1) 
 
or 
 
phantom
phantom
patientpatient zyxAD
zyxM
zyxADzyxED
)',','(
)',','(
),,(),,( =    (2.2) 
   
Where ED is Expected Dose, AD is ADAC-Dose and (x,y,z) are the coordinates 
in the patient system 
 
This means that if the phantom measurement confirms to the phantom calculation 
performed by the ADAC algorithm then the ED (x,y,z)patient should be equal to the                     
AD (x,y,z)phantom as well.   
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 A difference of ±5% maximum has been set to accept the plan to be delivered in 
the patient [10, 11, 1, 3]. This percentage range is set to overcome the uncertainties given by 
the instrument of measurement, the point of measurement of a region of high dose 
gradient, output variation from day to day in clinacs and/or multi- leaf controllers [10] and 
others.  If differences between measured dose  )',','( zyxM phantom and dose calculated by 
ADAC  AD )',','( zyx phantom are more than 5%, further investigation needs to be done.   
 The process of doing quality assurance for IMRT fields is not the same at all 
institutions. Pre-delivery verification in general includes [12]: 
a) Delivery of patient plan to film or to diode detectors; 
b) Measurement of dose and dose profiles; 
c) Display of the isodose distribution; and 
d) Verification of non-collision during treatment. 
 
In other words, dose verification includes point dose measurement with an ion 
chamber, film or diodes. It also includes two dimensions relative dose distribution 
measurement using film or diodes array. Finally, IMRT QA could include the verification 
of the fluence pattern perpendicular to the incident beam using a device such as electronic 
portal imaging device (EPID) or films [13]. 
X-OMAT V (XV) film from Kodak is the most common radiographic film used 
for relative dose distribution measurement for IMRT [13, 11]. However, a one-dimensional 
diode array could also provide relative dose measurements at discrete locations in one 
dimension (profiles). In fact, papers have been published where a one-dimensional diode 
array, the Profiler model 1170 by Sun Nuclear Corporation, has been used to measure the 
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relative dynamic multi- leaf output for all the leaves simultaneously [1].  Besides, Sun 
Nuclear Corporation has enhanced the profiler model 1170 with new improved detectors 
which are the same of those used in the Mapchek. Therefore, the Profiler could be used to 
do certain tasks performed in the IMRT verification. 
 MBPCC is using film dosimetry to perform the IMRT QA for each patient. 
Having two alternative ways to perform certain tasks in the IMRT verification process 
can open the possibility not only to improve the accuracy of the quality assurance but 
also to make further research in the quality assurance process. 
When doing the IMRT QA at Mary Bird Perkins, the following measurements are 
performed for each IMRT field: 
I) measurement of dose at a selected point; 
II) measurement of  relative dose along a line containing the selected 
point of measurement (vertical and horizontal profiles); and 
III) measurement of the two dimensional isodose distribution. 
 
These measurements are performed using film dosimetry. This thesis project aims 
to verify if the Profiler (one linear diode array designed by Sun Nuclear Corporation) can 
be used as a tool for IMRT QA.  
The key for a successful clinical implementation of IMRT is to establish a 
dosimetry verification process that can ensure that the plan to be delivered to the patient 
is efficient, safe and consistent with the dose calculated for each patient. 
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CHAPTER 3 
MATERIALS AND METHOD 
Varian Clinac 21EX 
A Clinac Varian 21EX has been used in this project. Two energies (4, 10 MV) are 
produced in this machine when used in photon mode and five energies (6, 9,12,16,20 
MeV) are produced when used in electron mode. The Model 21EX is one of the latest 
Varian Models that when equipped with multi- leaf collimation is possible to deliver 
treatment by intensity modulated radiotherapy technique.  The multi- leaf collimator         
(MLC) consists of 120 leaves arranged in opposed pairs. The Forty central opposed pairs 
are 2.5 mm wide and 10 cm thick, while the 10 opposed pairs at each side are 5mm wide. 
These leaves attenuate the X-rays by a factor of about 100[9]. In order to reduce the 
leakage between leaves, the side of each leaf is dovetailed with the neighboring leaves. 
Each leaves moved in and out by small electronic motors controlled by computer.  Figure 
3.1 shows a picture of the multi- leaf. 
 
 
 
 
 
 
 
 
 
Figure 3. 1    Multi- leaf Collimator for clinac 21EX. 
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Radio-frequency electromagnetic waves are used by a linear accelerator (Linac) to 
accelerate charge particles (electrons) through a linear tube so that they can gain high 
energy.  Figure 3.2 shows the major components of a clinical linear accelerator (C linac). 
 
 
                      
 
Under vacuum conditions, electrons are injected by the electron gun in the 
accelerating structure.  A power supply provides DC power to the modulator which in 
turn delivers DC pulses of a few microseconds in duration to the magnetron or klystron 
and simultaneously to the electron gun.  The magnetron or klystron produces pulsed 
microwaves (~3000MHz) that are injected to the accelerator tube by a wave guide 
system. When electrons are injected by the electron gun into the accelerating structure, 
they interact with the electromagnetic field of the microwaves emitted by the magnetron 
or klystron.  
 Figure 3. 2    Major Components for a typical clinical linear accelerator. 
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Energy is gained by the electrons as they are accelerated by the sinusoidal electric field.  
At the end of the accelerator tube, the electron beam pass through bending magnets 
which bend it 270°.   In order to produce photons, the electron beam hits a tungsten target 
and x-rays peaked in forward direction are produced [14, 15]. A flattering filter is inserted 
to make the x-ray beam uniform across the field.  After passing through the ion 
chambers, which monitor the beam for dosimetry and quality assurance purposes, the 
beam is collimated by a secondary set of x-ray collimators (see Figure 3.4).  The 
collimators are two pair of tungsten blocks (jaws) to give a rectangular opening ranging 
from 0x0 to 40x40 cm projected at 100 cm from the x-ray source. Figure 3.3 shows the 
Clinac used in this project. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. 3   Clinical Linear Accelerator Varian 21EX. 
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Figure 3.4   Scheme of the X-Ray Therapy mode of Clinacs. 
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Electrometer 
The Keithley 614 (SN/312250 ) electrometer was used in this project. This electrometer 
is capable of performing four functions: current, charge, resistance, and voltage. The 
charge mode, the mode used in this project, has a sensitive ranging from 10-14 to 2X10-8 
coulombs [16]. This instrument has internal electronic static bias supply of -150V, -300V, 
OFF, +300V and +150V. It has a leakage less than 6X10-14 A.  The electrometer was 
calibrated at The University of Wisconsin-ADCL. Figure 3.5 shows the electrometer used 
in this project. 
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 3.5    Electrometer Keithley  614. 
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Ionization Chambers  
A  PTW Farmer-type ionization chamber was used in this project. The model N30013 
(SN/0579) was used to measure the dose.  It also has an official calibration from 
University of Wisconsin-ADCL. This ion chamber has a nominal sensitive volume of 0.6 
cm3, 6.1 mm internal diameter and 23 mm long. The thimble is made out of 0.335-mm 
acrylic wall with a density of 56 mg/cm2. It uses an aluminum collecting electrode 1.1 
mm diameter and 21.2 mm long. The maximum leakage is   ±4X10-15A with a bias 
voltage of 500V [17]. It is a waterproof chamber. Figure 3.6 shows the PTW ion chamber 
model N30013. This chamber was used to measure dose at different points and selected 
depths in the plastic water-equivalent. 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6   Ion Chamber PTW Farmer-Type model N30013. 
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  The second type of ion chamber used in this project was the slimline micro-
chamber of Exradin Standard Imaging Model A16, SN/XAA030841 .  It has  a nominal 
collecting volume of  0.007 cm3 and a collector diameter of 0.3mm made of shonka air 
equivalent plastic C552[18] .  The centroid of collecting volume is approximately 1.7 mm 
from the tip of the chamber. It has 0.5 mm wall thickness. Figures 3.7 and 3.8 show the 
slim micro chamber Exradin Standard Imaging Model A16. 
This ionization chamber was used to get relative measurement only. 
 
 
 
 
 
 
 
 
 
Figure 3.7  Slimline Micro-chamber  Exradin Standard Imaging Model A16. 
Figure 3.8.  Ion Chamber  Exradin Standard Imaging Model A16. 
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Phantom 
A Phantom is a medium with electronic density close to tissue and it is used to make 
radiation dosimetry measurement. Due to the fact that human body is made mostly of 
water, the best representative of the human body when interacting with radiation is water.  
To eliminate the inconvenience of transporting, setting up and filling water tanks, a 
plastic water-equivalent or solid water has been designed to make radiation dosimetry 
measurement. These phantoms are usually within 0.5% of true water dosimetry.  
The slabs of plastic water used as a phantom in this project are shown in Figure 
3.9. This material is made of epoxy resins with a mass density of 1.02 g/cm3 . The 
dosimetry done using this phantom material agrees with true water within 0.05% - 0.4%. 
 Due to the fact that it has the same electron density and atomic number close to 
water, this material has the same scattering and stopping power as true water. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9       30x30 cm slabs of plastic water. 
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One-Dimensional Linear Diode  Array 
The Profiler Model 1170 designed by Sun Nuclear Corporation is a one-dimensional 
linear diode array. It consists of 46 high resolution solid state detectors with an effective 
detection size of 0.8x0.8 mm each. They are radiation hardened n-type diodes. These 
detectors are spaced every 5 mm making a total array length of 22.5 cm. It has a total 
inherent build up to detector junction of    1.00 ± 0.1 g/cm2 made of acrylic, and an 
inherent backscatter of 2.3 cm of acrylic [19]. These detectors have a superior radiation 
resistance with a radiation degradation rate of about 2% /KGy for 10 MeV electron beam. 
They have minimized instantaneous dose rate dependence. The diodes response variation 
when using photon is less than ±2% for 18 MV and less than ±1%  for 6 MV from 80 to 
130 cm for a typical accelerator. They have an outstanding stability and no significant 
change in SSD dependence is measured in photon beams.  They are useful for energies 
ranging from Co-60 to 25 MV for photons and from 6 to 25 MeV for electrons. The 
temperature variation is about 0.5%/°C [19].  Figures 3.10 and 3.11 show the Profiler. 
The Profiler was calibrated against an ion chamber to read dose directly.  
 
 
 
 
 
 
 
Figure 3.10  Profiler Model 1170 designed by Sun Nuclear Corporation. 
  20 
 The additional accessories used to connect the Profiler to the laptop computer are 
mentioned below (Figure 3.11). 
1. Power supply for Profiler 
2. line power cord, IEC plug to USA style 
3. Serial cable, 9 pin D type, 2m 
4. Buildup plate, 1 cm acrylic 
5. Power serial data cable, 8 pin DIN, 25m 
 
 
 
 
 
 
 
 
 
 
 
The following items were also material and equipment used in this project. 
Barometer.  Taylor brand. 
Thermometer.  Fisher-brand  ranging from -20° to  110° . 
Films . Kodak ready pack X-OMAT V Films. 
Processor. Kodak X-OMAT 270RA processor. 
Figure 3.11      Profiler and accessories needed to hook up to the computer. 
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Film Digitizer.   Vidar VXR-12 digitazer. 
RIT113  Software .  Radiation Therapy Film Dosimetry System. 
Dell  Desktop Computer 
HP Laptop Computer 
Equipment Setup 
 In this project, the first step taken to measure absolute dose was to check the 
output given by the accelerator. It is important to verify that the accelerator is given the 
dose rate that is expected to give at a particular point. The output for clinacs is usually set 
to be 1 cGy/MU for a 10x10 cm field size at depth of maximum dose at 100 cm source to 
surface distance (SSD) or 100 cm source to chamber distance (SCD) in water. To do this 
verification an ion chamber, with absorber-dose to water factor, 60-CowN , which is 
traceable to National Institute of  Standards and Technology (NIST), was used. The 
absorbed dose to water at a point of measurement of the ion chamber when it is absent is 
given by 
 
600-= CwQ
Q
w NMkD                   (3.1) 
 
Were QwD   is the absorbed dose to water in cGy, M is the fully corrected electrometer 
reading in coulombs (C) and kQ is the quality conversion factor[6]. The NIST calibration 
gives absorbed dose to water, QwD , only for Co-60 energy, so kQ is an energy correction 
factor for a  beam of quality Q.  kQ is ion chamber specific and they are tabulated in table 
I of AAPM’s TG-51 protocol for the most common ion chambers and energies used[6]. 
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 The value of M is the fully corrected electrometer reading which is given by  
rawPolelecTPion MPPPPM =     (3.2) 
Were Mraw is the raw in Coulombs (C), uncorrected ion chamber reading, Pion corrects for 
ion recombination [6]. In other words, ion chamber reading in the user’s beam must be 
corrected for lack of complete collection efficiency. The two voltage technique is usually 
used to determinate this factor. This involves measuring the charge produced by the ion 
chamber in the beam of interest when two different bias voltages are applied to the 
detector. It is calculated using Equation 3.3. 
150
300
-
-=
M
M
Pion                 (3.3) 
PTP is the factor that corrects the reading for environmental conditions.  Standard 
environmental condition in which the ion chamber has been calibrated is different than 
the environmental condition where the measurement is being taken. This factor is 
calculated using Equation 3.4.  
)(
760
*
2215.273
)(15.273
mmHgP
CT
PTP oo
oo
+
+
=              (3.4) 
 Pelec is electrometer correction factor for the scale being used. This factor is 
obtained from an Accredited Dosimetry Calibration Laboratory (ADCL). 
 Ppol is the factor for chamber polarity effect. In order to correct the ion chamber 
raw reading for this factor, readings with both polarities need to be taken and Ppol will be 
given by 
raw
rawraw
pol M
MM
P
2
-+ +
=                 (3.5) 
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Where +rawM   and  
-
rawM   are the readings when positive or negative bias is applied to the 
central electrode.  Mraw is the reading given by the electrometer by the time of 
measurement [8]. 
 Thus, the absorbed dose to water at the point of measurement can be determinate 
by using an officially calibrated ion chamber and electrometer, and applying Equation 3.1 
and 3.2.   
 
60-= CowQrawpolelecTPion
Q
w NkMPPPPD                (3.6) 
 
There is still another factor that is applied to Equation 3.6.  That is  
tissue
water
÷÷
ø
ö
çç
è
æ
r
m
 
factor. This factor is used to correct the tiny but no neglected difference between water 
and tissue. It is the ratio of the attenuation coefficient of tissue and water. 
Measuring Accelerator Output 
The accelerator output was measured using a waterproof ion chamber in a water 
tank.  The water tank was filled up so that it had at least 30 cm depth of water. The 
surface of the water was set to 100 cm from the photon source.  The ionization chamber 
was placed 10 cm below the level of the water as recommended by the TG-51 protocol 
and collimators were open so that a 10x10 cm field size was projected at the surface of 
the water [8] . AAPM’s  TG-51  was followed. Figures 3.12 and 3.13 show the setting for 
this measurement. 
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Figure 3.12     Water tank and ion chamber a depth of  Dmax. 
Figure 3.13   Clinac and Water Phantom setup. 
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Three different reading at 10 cm depth were taken for each measurement. 100 MU 
were used to collect each reading. The measurements were done by using +300V, -300V, 
-150V bias voltages.  4 MV photon beam energy was used. Each reading for every 
measurement is given in Table 3.1. The ion chamber is always used with a negative bias 
voltage 
 
 
Using the data in Table 3.1, every factor in Equation 3.6 can be calculated to determine 
the absorbed dose to water.  Pion can be found from Equation 3.3. 
  0022.1
164.1
1666.1
==ionP   
PTP    can be found from Equation 3.4.  When doing this measurement the temperature 
and the pressure were respectively 29°C and 758 mmHg. 
0264.1
758
760
*
15.295
2915.273
=
+
=
o
oo
TPP  
Pelec is given by ADCL. ( Pelec= 1.000E-8 C/Rdg ). 
Ppol can be found from Equation 3.5 
Bias MU M1 M2 M3 AVE 
+300 100 1.165 1.161 1.164 1.163 
-300 100 1.167 1.166 1.167 1.1666 
-150 100 1.165 1.162 1.166 1.164 
-300 25X4* 0.292 0.583 0.875 1.166 
* 4 burst of irradiation of 25 MU each were delivered. The value in column AVE is the 
total sum.  
Table 3.1    Collected data to verify the output of the clinac. 
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998.0
1666.1*2
163.11666.1
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=polP  
kQ is obtained from figure 4 in AAPM’s TG-51 protocol [8] and it has a value of 0.997 for 
4 MV and the ion chamber used in this project (PTW N30013). 60-CowN  is given by  The  
Accredited Dosimetry Calibration Laboratory and it has a value of 5.285X7 Gy/C for the 
ion chamber used in this project. 
 Therefore, the absorbed dose to water at a point of measurement for 100 MU is 
given by Equation 3.6. the tissue-water correction factor is also applied. 
tissue
water
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wQrawpolelecTPion
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GyDQt 1
100
*62499.0  62.499 cGy 
The above dose is given at the reference point, 10 cm depth in water. In order to 
determine the dose at depth of maximum dose, a dose depth fraction at 10 cm for 10x10 
cm field size and 4 MV need to be applied.  
max*)4,1010,10( DDDFD MVX
Q
t =        (3.8) 
==
6214.0
499.62
max
cGy
D    100.5793 cGy 
DDF was obtained from the dosimetry data for this machine. 
 The dose rate is given by 
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max
eemu
D
D
+
=
·
            (3.9) 
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Where ee is the end effect, the still electron collection after beam is off. It is found by 
using the following equation 
 
254300
300254
4
)(*100
x
x
MM
MM
ee
-
-
=
-
-                 3.10 
Where M-300 is the reading obtained when using 100 MU and -300V bias voltage and 
M4x25 is the reading obtained when using 4 times 25 MU at the same bias voltage. The 
end effect is, therefore  
=
-
-
=
1666.1)166.1(4
)1666.1166.1(*100
ee  -0.017 
 
Thus, by applying Equation 3.9 the dose rate is 
 
=
-
=
·
mu
cGy
D
)017.0100(
5793.100
max  1.006 cGy/MU 
The above value is called the output and it can be expressed as 
=
·
)100,4,1010(max SSDMVxD  1.006 cGy/MU 
Output Measurement in Plastic Water 
The output was also measured in plastic water. Due to the fact that all the measurements 
with ion chamber were done using plastic water, it is important to be sure that the 
absorbed dose to water is similar to the absorbed dose to plastic water. The following 
setup was used to measure the output. Ion chamber was placed at depth of maximum dose 
(Dmax=1.2 cm for 4 MV photons), 20 cm of plastic water were used as backscattering. 
Collimators were open to a 10x10 cm field size projected at the surface of the solid water. 
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The surface of the solid water was at 100 cm from the photon target (SSD=100 cm). The 
ion chamber was irradiated by using 100 MU of 4 MV photon beam. Five reading were 
taken and the average was taken as the Mraw. 
9228.1
5
925.9231.1924.1922.1920.1
=÷
ø
ö
ç
è
æ +++=rawM  rdg 
The temperature and pressure at the time of measuring was 22.6° and 758 mmHg 
respectively.  The absorbed dose was calculated by using Equation 3.7. 
=+-= )99.0)(/8285.5)(997.0)(9228.1)(998.0)(/8000.1)(004.1)(003.1( CGyERdgCED  
D=1.008Gy*(100cGy/Gy) = 100.8 cGy 
The dose delivered by 100 MU at dmax, 10x10 cm, SSD=100 cm, 4 MV in true water is 
100.6 cGy.  The difference is  
%19.0%100*
6.100
8.1006.100
% =÷
ø
ö
ç
è
æ -=  
This percentage is small so we can use plastic water instead of true water for clinical 
dosimetry. 
Profiler Setup 
Before taking any measurement with the Profiler, a diode array calibration for the 
energy used need to be performed.  Each diode has a different sensitivity so the array 
calibration measures the relative sensitivity differences between the diodes in the Profiler 
and stores correction factors which are applied to the raw data before displaying a profile. 
Figures 3.14 and 3.15 show the profile of a 10x10 cm field size normalized to the 
central diode when correction factor is applied (3.15) and when it is not (3.14). 
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Graph of diode array wihtout correction 
factor (10x10 cm) field size
0
0.5
1
1.5
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diode number
Graph of diodes array with correctiion 
factor (10x10 cm) field size
0
0.4
0.8
1.2
0 10 20 30 40 50
diode number
Figure 3.14  Profile of 10x10 cm field  without array calibration. 
Figure 3.15  Profile of 10x10 cm field with array calibration. 
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 The calibration is a simple procedure and takes only a few minutes to do it. It was 
done following the steps given in section 3, page 15 of the Profiler User’s Manual [6].   
 When placing the Profiler in a photon beam, the raw integrate values for each 
diode and its correction factor are saved as TXT file. 
 Two modalities may be used to make measurement with the profile; dose rate and 
dose.  When using dose, the total dose due to the two central detectors is shown in the 
data dock which is located in the right hand side of the Profiler display (see Figure 3.16). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.16 .  Dose is shown in data dock of the Profiler display. 
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This dose, given in cGy, is calculated from the total dose measured by detector 23 
and 24. It is the average of the dose obtained from the two detectors.  This dose is 
calculated from the dose rate factor “K” determined during the array calibration. This 
“K” factor can be edited and adjusted to yield a more accurate value of dose. 
 The following equation is needed to adjust the “K” value in order to have more 
accurate absorbed dose measurements. 
ofilerDose
eChamberDos
KoldKNew
Pr
*=            (3.10) 
Adjusting the “K” Value in the Profiler 
 To adjust the “K” value in the Profiler, the ion chamber in plastic water was used 
to measure absorbed dose at a point of reference. The ion chamber was placed at the 
isocenter , SAD=100 cm, with 5 cm of plastic water above and 6 cm of plastic water as 
backscattering. Collimators were open to 10x10 cm and 100 MU were delivered. 
Temperature and pressure at that time was 22°C and 761 mmHg respectively. Five 
reading were taken and the average was used to calculate the absorbed dose to water. 
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Equation 3.7 was used to calculate the absorbed dose. 
D = 91.9 cGy 
 After finding the absorbed dose to water at that point, the Profiler was placed in 
the beam using the same setup. Due to the fact that the diode array has an inherent 
buildup of about 1.0 g/cm2 of acrylic, only 4 cm of plastic water were placed over the 
Profiler surface. The diode array was located at the isocenter. 100 MU were delivered. 
Ten readings were taken and the average was taken as the absorbed dose. 
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The new “K” value will be given by applying Equation 3.11 
New K= Old K*(91.9/88.325) =  0.088686 
The old K with a value of 0.085236 was changed by the new one. Figure 3.17 shows the 
window to edit the “K” value. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
After that, new measurements were made using the same Profiler setup in order to 
verify if the values reading in the Profiler display were the absorbed dose expected. 
Ten reading were taken and the average was used as the absorbed dose. 
 
Figure 3.17.   Window to edit the “K” value. This window can appear by 
clicking [Calibration] in the bar menu and [Edit K value] in the sub-menu. 
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Verification Of TMR  in the Profiler 
TMR is the Tissue-Maximum Ratio and it is defined as the ratio of the dose at given 
point in phantom at depth d to the dose at the same point at the reference depth of 
maximum dose [14]. This is 
( ) )(
)(
max
,, dD
dD
TMR
p
p
depthfieldSize =g            (3.12) 
 
 
 
 
Figure 3.18  Diagram illustrating the Tissue-Maximum Ratio definition 
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Figure 3.18 shows a diagram illustrating the Tissue-Maximum Ratio definition. 
TMR depends on field size and energy. However, it is independent of SSD. 
  TMR was measured in plastic water using the ion chamber and the Profiler.  A 
10x10 cm field size and 4 MV photon energy were used.  First, measurements at different 
depth were made using the ion chamber. One hundred monitor units were delivered for 
each measurement. Immediately after, measurements at the same depth were made using 
the Profiler. One hundred monitor units were also delivered for each measurement. TMR 
was determined using Equation 3.12.  Table 3.2 shows data for both ion chamber and the 
Profiler, and Figure 3.19 shows the graph of the values. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Depth  (cm) Ion Cham. Profiler % Diff 
1.2 1 1 0 
2 0.9917 0.9912 -0.05% 
3 0.9645 0.9649 0.04% 
4 0.9348 0.9352 0.04% 
5 0.9025 0.9045 0.22% 
6 0.8701 0.8705 0.04% 
9 0.7665 0.7671 0.08% 
11 0.6988 0.7013 0.35% 
13 0.6367 0.6398 0.48% 
16 0.5505 0.5532 0.49% 
Table 3.2.   TMR values obtained with ion chamber and the Profiler. 
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Verification of Scp Factor 
Scp is the factor that take into account scattered radiation added to the primary 
beam due to the interaction of the beam with the collimators and with the phantom 
medium. As collimators are opened, larger area of collimators will interact with the 
beam, and more scattering will be added to the primary beam. When collimators increase 
the field size, the volume of medium being irradiated also increases and therefore, more 
scattered radiation will contribute to the absorber dose. 
 To determine the Scp factor, absorber dose at the reference point is measured for 
different field sizes and normalized to the 10x10 cm field size.  These measurements are 
usually taken at depth of maximum dose. However, in this project data were collected at 
5 cm depth with ins trument located at isocenter, SAD=100 cm. This measurement was 
made just to check if the Profiler was really measuring the actual dose given by different 
field sizes at 5 cm depth. These values were not used at all in any calculations. 
Figure 3.19   Plot of TMR data obtained with ion chamber and Profiler. Field  
            size 10x10 cm, 4 MV, 100 SSD. 
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First, measurements were made using the ion chamber. The ion chamber was 
placed at isocenter, SAD=100 cm, with 5 cm plastic water above the detector, and 6 cm 
plastic water as a backscattering. 100 MU and 4 MV photon beam were delivered for 
each measurement. See collected data in Table 3.3. 
 Immediately after, measurements were taken by using the Profiler. Four 
centimeter of plastic water on the surface of the Profiler and the diodes were placed at 
100 cm from the photon source. The data collected for the different field size were 
normalized to the 10x10 cm field size.  Table 3.3 shows the values of Scp for the different 
field size. Figure 3.20 shows the graph of the Scp values obtained with both the ion 
chamber and the Profiler. 
 
 
Field Size Ion Chamber Profiler %Diff 
3x3 0.8501 0.8548 0.55% 
4x4 0.8933 0.891 0.25% 
5x5 0.9211 0.9174 0.40% 
6x6 0.9438 0.9413 0.26% 
8x8 0.9761 0.9753 0.08% 
10x10 1 1 0 
12x12 1.0204 1.018 0.23% 
15x15 1.0408 1.0404 0.03% 
18x18 1.059 1.0574 0.15% 
20x20 1.0669 1.0666 0.02% 
Table 3.3.   Scp Factor  measured by using Ion chamber and Profiler. 
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Measurement of Dose for IMRT Fields  
 Two different IMRT fields were chosen from a real neck case in order to have 
measurements of dose at two different points.  The measurements of dose were taken by 
using film, ionization chamber and the Profiler. 
 Figure 3.21 and 3.22 show the ADAC map with the dose distribution for the two 
fields selected in this project. These distributions are in plastic water phantom. With the 
naked-eye one can see in the picture the areas of higher dose. The whiter the area, the 
higher the dose and the darker the area the lower the dose. In fact, the completely black 
area means no dose at all. It is the inverse of an exposed film. 
 
 
Figure 3.20   Scp factor measured with ion chamber and Profiler at 5 cm depth, 100 cm SSD, 
  4 MV. 
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 Figure 3.22  Map of dose distribution for field B. 
Figure 3.21   Map of dose distribution for field A. 
P 
Q 
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Q 
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The specification of each field is given in Table 3.4 
 
 
 Collimator  
Field X1 (cm) X2 (cm) Y2 (cm) Y1 (cm) Energy MU 
A 8.0 6.5 11.0 4.5 4 MV 148 
B 3.0 11.5 11.0 4.5 4 MV 99 
 
When using films, these are placed between two 5 cm slabs of plastic water and 
film located at 100 cm from the photon source (100 cm SDD). This is the normal setup 
when doing the quality assurance of Intensity Modulated Radiation Therapy treatments. 
When using ionization chamber, it was placed 100 cm from photon source with 5 cm of 
plastic water above the chamber and 6 cm of plastic water below the chamber for 
backscattering. When using Profiler, the linear diodes were placed at 100 cm from the 
photon source with 4 cm of plastic water on top the surface of the Profiler. The Profiler 
has an inherent build up of 1 cm water equivalent. 
The coordinates of the point of measurement are given in Table 3.5. 
 
 
 
  Point P     Point Q   
  X (cm) Y (cm)   X (cm) Y (cm) 
Field A 0 0   -4.5 -1.5 
Field B 0 0   1.5 -6 
 
Table 3.4   Specification of field A and B. 
Table 3.5.  Coordinates of point of measurement.  Values 
       given in cm from the center (0,0).  
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Step 1 
The dose was measured at point P (see Figures 3.21 and 3.22).  Point P is the center (0,0) 
of the collimator opening and where the cross-hair is projected.  Five different 
measurement using film, ionization chamber and Profiler were made at point P.  Each 
measurement was taken at least within 3 days apart to account the daily variation of the 
Linac.  Horizontal and vertical profiles at point P were also taken. 
 
Step 2 
 After that, the off-axis factor (OAF) for 5x5 cm, 3x3 cm and 2x2 cm field size 
were determined.  The off-axis factor is defined as the ratio of the dose at any point in the 
field area to the dose at the central point of the field at the same depth. 
 
 
                
0D
D
OAF p=      (3.13)                
 
 Where Dp is the dose to any point in the field and Do is the dose to the central axis 
for the same depth. 
 This test was done using the ion chamber PTW N30013, the slimline 
microchamber Exradin Standard Imaging A16, and the Profiler. The PTW N30014 ion 
chamber was placed at 100 cm SDD (Source Detector Distance) from the photon source 
with 5 cm of plastic water over it and 6 cm of plastic water for backscattering. One 
reading was made in that position and then it was shifted 5 mm along the X-axis to have a 
new reading. Readings were taken along the X-axis every 5 mm until no reading was 
o*       *p 
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obtained. This process was done for 5x5 cm, 3x3 cm and 2x2 cm field size.  For each 
measurement 300 MU and 4 MV photon beam were delivered. 
 The same setup was used with the slimline micro-chamber. However, 500 MU 
were delivered because of the size of the chamber and measurements were taken for 3x3 
cm and 2x2 cm field size.  
 When using the Profiler, the detectors were placed at 100 cm from the photon 
source. 4 cm of plastic water were placed on top. 300 MU and 4 MV photon beam were 
delivered for each measurement. The test was done for 5x5 cm, 3x3 cm and 2x2 cm field 
size. Measurements were taken by placing the diode array perpendicular and parallel to 
the line of movement. 
Step 3 
 Dose was measured at point Q in the IMRT fields A and B. (see Figure 3.21 and 
3.22).  The point Q is located at (-4.5, 1.5) from point P (the center) for field A and at 
(1.5, 6.0) for field B.  Point Q has a dose higher than the dose at point P. Actually Q is the 
point of highest dose in the fields. 
 Three different measurements were taken at this point. Ion chamber, films and 
Profiler were used to do the dosimetry. The vertical and horizontal profiles were also 
collected.  Each measurement was taken with at least 3 days apart.  
Step 4 
 A complete patient treatment plan was selected to perform the IMRT QA. Ion 
chamber, films and the Profiler were located using the same setup that was used in step 1 
and 3. The case was chosen because the first quality assurance performed using film 
dosimetry showed a large variation from the dose calculated by ADAC  algorithm. In 
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other words, the dose obtained when using film was different by more than 5% respect to 
the dose given by ADAC planning.  
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CHAPTER 4 
RESULTS AND DISCUSSION 
 
Five different measurements were taken with each instrument when measuring the 
absorbed dose at point P for the IMRT fields used. The data is shown in Table 4.1 and 4.2 
 
 
  
M1 
cGy 
M2 
cGy 
M3 
cGY 
M4 
cGy 
M5 
cGy 
AVE 
cGy 
STD 
cGy 
%STD 
 
Ion Ch. 35.73 35.71 35.64 35.71 35.85 35.73 0.076 0.21 
Film 36.6 36.25 37.41 36.8 34.83 36.38 0.962 2.65 
Prof V 32.17 30.42 32.35 32.68 34.44 32.41 1.433 4.42 
Prof H 32.85 34.27 34.69 33.51 35.59 34.18 1.058 3.09 
 
 
 
 
 
 
 
The average of the absorbed dose given by film, ion chamber and the Profiler and the 
difference respect to the absorbed dose given by ADAC are shown in Table 4.3.   
 
 
 
 
  
M1 
cGy 
M2 
cGy 
M3 
cGy 
M4 
cGy 
M5 
cGy 
AVE 
cGy 
STD 
cGy 
%STD 
cGy 
Ion Ch. 34.72 34.56 34.54 34.62 34.62 34.61 0.07 0.20 
Film 33.98 35.61 34.6 34.41 31.71 34.07 1.444 4.24 
Prof V 33.89 33.92 34.01 34.14 34.3 34.05 0.169 0.50 
 Prof H 34.23 33.97 34.02 34 34.08 34.06 0.104 0.30 
Field 
 
ADAC 
cGy 
Ion Ch. 
cGy 
%diff 
 
Film 
cGy 
%diff 
 
Prof. H 
cGy 
%diff 
 
A 36.65 35.72 -2.52 36.39 -0.7 34.18 -6.72 
B 35.33 34.61 -2.03 34.07 -3.56 34.06 -3.61 
Table 4.1   Absorbed dose at point P, Field A.   
Table 4.3   Absorbed dose differences in relation to the dose given by the  
        ADAC computer. 
Table 4.2   Absorbed dose at point P, Field B.   
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To get the absorbed dose when using films, the scanner VXR-12 and RIT113 
software were used. In Appendix D is explained how to get doses and profiles data when 
using film dosimetry.  Absorbed dose obtained with the ion chamber was calculated by 
using Equation 3.7 and absorbed dose obtained with the Profiler was directly read from 
the Profiler display. In Appendix D is explained how to extract the dose detected by each 
detector of the diodes array from the TXT file created after the measurement is made. 
 The horizontal and vertical profile in point P was also taken. The data obtained in 
each measurement using films and the Profiler is shown in Appendix A.  The plot of 
average profile given by film and the Profiler is shown in Figure 4.1, 4.2, 4.3 and 4.4. 
The bar error shown in ADAC data is the 5% tolerance allowed when comparing with 
film dosimetry.  Because the Profiler collects discrete measurements, they are represented 
with dots in the graph.  
 The plot given by the RIT113 system when using film dosimetry is also shown in 
Appendix B. (see Figures B.1, B.2, B.3 and B.4) 
From Table 4.3, one can see that difference between the dose measured by the 
Profiler and the dose calculated by ADAC is 6.72% different in field A. However the 
difference between the dose measured by the Profiler and the dose measured by ion 
chamber is 
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Figure 4.1. Horizontal profile at point P, field A.  The graph shows the 
profile given by ADAC, film and Profiler. 
Figure 4.2.   Vertical profile at point P, field A.  The graph shows  
          the profile given by  ADAC, film and Profiler. 
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Figure 4.3.   Horizontal profile at point P, field B.  The graph shows the  
           profile given by ADAC, film and Profiler. 
Figure 4.4.   Vertical profile at point P, field B.  The graph shows  
           the profile given by ADAC, film and Profiler. 
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Difference is even less for field B.  Look at Table 4.3; Figures 4.1 and 4.2, the 
Profiler underestimates the dose at point P. From Figure 3.21, it can be noted that point P 
is not the point of maximum dose. In fact, if searching carefully in the dose distribution 
for that field, we note that the dose at point (0, 0) is around the half of the dose at point  Q  
(-4,-1.5).  Look at Table A.9 in Appendix A. The dose absorbed in point P is mostly due 
to the primary beam through that point and certain amount due to scattering from nearby 
fields being irradiated. The underdose obtained when measuring point P made us to 
suspect about the capability of the linear array to measure dose when they are out of the 
radiation field. In other words, are the diodes capable to detect scattering from irradiating 
adjacent areas?  Further, the dose obtained with the Profiler is different when the 
detectors are turn around.  It leads us to check the Profiler for off-axis (OAF) factor.  To 
make this measurement, the middle distance between the two central diodes of the 
Profiler was placed in the center of the field size. After making each measurement, the 
Profiler was shifted 5 mm to take the next measurement.  Measurements were taken for 
5x5, 3x3 and 2x2 cm field size.  The diode array was placed perpendicular and parallel to 
the line of the movement.  The slimline Exradin chamber was also used to have 
measurement in fields 3x3 and 2x2 cm.   Tables 4.4, 4.5 and 4.6 show the values obtained 
and Figures 4.5, 4.6 and 4.7 are the respectively graphs. 
As we can see in Tables 4.4, 4.5, 4.6, the position of the diodes really matter when 
measuring dose in the border of field.  It can clearly be seen that going beyond the border 
of the field, diodes will respond similarly to ion chamber when the detectors are placed 
parallel to the line of movement. 
 
 48 
 
 
cm off 
Profiler (%) 
Diode Perp.( ^  ) 
Profiler (%) 
Diodes Paral ( || ) 
PTW 
(%)Chamber 
0.0 100.00 100.00 100.00 
0.5 100.00 100.00 100.00 
1.0 100.00 98.99 100.00 
1.5 98.87 97.50 98.83 
2.0 93.60 84.91 92.02 
2.5 42.42 52.53 43.79 
3.0 8.92 12.43 7.93 
3.5 5.44 6.59 4.40 
4.0 0.05 4.61 3.21 
4.5 0.05 3.71 2.46 
5.0 0.00 3.04 1.94 
5.5 0.00 2.67 1.50 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.4.  Off-axis factor for field size 5x5 cm. Detectors at 100  
        cm, 5 cm depth, 4 MV.  
Figure 4.5.  Plot off-axis factor, 5x5 cm field size. 
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cm off 
Profiler (%) 
Diodes ( ^  ) 
Profiler (%) 
Diodes ( || ) 
PTW  (%) 
 
Exradin  (%) 
 
0.0 100.00 100.00 100.00 100.00 
0.5 100.00 100.00 100.00 100.00 
1.0 94.20 93.62 97.00 96.87 
1.5 34.71 55.69 56.06 51.04 
2.0 6.90 12.69 11.79 5.20 
2.5 0.00 4.67 3.31 0.00 
3.0 0.00 3.27 2.18 0.00 
3.5 0.00 2.63 1.60 0.00 
4.0 0.00 2.03 1.22 0.00 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.5.  Off-axis factor, field size 3x3 cm. 
Figure 4.6.  Plot  off-axis factor for 3x3 cm field size. 
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cm off 
Profiler (%) 
Diodes ( ^  ) 
Profiler (%) 
Diodes ( || ) 
PTW  (%) 
 
Exradin (%) 
 
0.0 100.00 100.00 100.00 100.00 
0.5 96.03 93.33 96.45 94.60 
1.0 38.69 50.13 57.00 43.56 
1.5 0.00 8.84 7.35 3.12 
2.0 0.00 3.32 2.44 0.00 
2.5 0.00 2.24 1.54 0.00 
 
  
 
 
 
Table 4.6   Off-axis factor for 2x2 cm field size.  
Figure 4.7.  Plot  off-axis factor for 2x2 cm field size. 
Off-axis factor 2x2 cm field size ( profiler, PTW 
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However, when the detector is placed perpendicular to the line of movement, no 
more dose is captured by detector after certain point.  This is due to the fact that the two 
central detectors, which are responsible to show the dose in the Profiler display, are 
located 2.5 mm to each side of the center. When the center of the Profiler is 5 mm from 
the border of the field, one of the detectors is actually 2.5 mm from the border of the field 
and the other 7.5 mm from the border.  When treating with IMRT treatment, multi- leaf 
collimation is capable to irradiate field size as small as 2.5x2.5 mm. It can make the 
difference when measuring dose with the Profiler. Of course, the reading in the Profiler 
window will be different when turning the profiler because the two central diodes are 
reading the dose from different places. The dose displayed in the Profiler window is the 
average dose of the two central diodes. 
 On the other hand, either position of the detector will detect no different dose 
when measuring in the center of the irradiation field.  It leads us to think that if 
measurement of dose is made in an area of uniform dose distribution, no significant 
variation is observed when using either position of the Profiler and ion chamber.  In other 
words, if we made measurement of dose in areas of low dose gradient, the results are 
similar whether we use ion chamber or the Profiler. If there is any difference when 
measuring dose with both position of the Profiler, the closest dose to the value given by 
ion chamber is taken. It is because one position of the diode array detects dose as similar 
as ion chamber does. (See Tables 4.4, 4.5, 4.6).   
  In next step, measurement were made at point Q. Q is the highest dose point in the 
field.  Table 4.7 and 4.8 show dose in point Q for field A an B measured using ion 
chamber, films and the Profiler.  
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M1 
cGy 
M2 
cGy 
M3 
cGy 
M4 
cGy 
M5 
cGy 
AVE 
cGy 
STD 
cGy 
Ion Ch. 60.40 60.73 60.72 60.46 60.56 60.57 0.15 
Film 62.42 58.79 60.97 60.82 62.13 61.03 1.43 
Profiler  V 60.79 60.59 59.11 59.10 59.24 59.77 0.85 
Profiler H 55.65 58.89 56.24 54.95 55.56 56.26 1.54 
 
 
  
M1 
cGy 
M2 
cGy 
M3 
cGy 
M4 
cGy 
M5 
cGy 
AVE 
cGy 
STD 
cGy 
Ion Ch. 41.12 41.14 41.39 42.27 41.55 41.49 0.47 
Film 44.05 41.68 42.68 43.37 44.39 43.23 1.09 
Profiler  V 42.14 42.08 42.23 42.34 42.20 42.20 0.10 
Profiler H 42.75 42.15 42.04 42.20 42.62 42.35 0.31 
 
 
Table 4.7 and 4.8 also show the absorbed dose measured by the Profiler in vertical 
and horizontal position. An important detail that can be observed is that field A has 
greater differences in the absorbed dose when measuring both position of the Profiler 
than field B does.  A closer look at Figures 3.21 and 3.22 will explain this.  Point Q in 
field A is near to a high gradient dose area but point Q in field B is further to a high dose 
area. 
The average of the absorbed dose given by film, ion chamber and the Profiler and 
the difference respect to the absorbed dose given by ADAC are shown in Table 4.9.   
 
 
Field 
ADAC 
cGy 
Ion Ch. 
cGy 
%diff 
 
Film 
cGy 
%diff 
 
Prof. 
cGy 
%diff 
 
A 60.83 60.57 -0.43 61.03 0.33 59.77 -1.74 
B 42.22 41.49 -1.73 43.23 2.39 42.35 0.31 
Table  4.7   Absorbed dose at point Q,  Field A.  
Table  4.8   Absorbed dose at point Q,  Field B.  
Table 4.9   Absorbed dose differences in relation to the dose given by ADAC. 
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As we can see on Table 4.9,   differences between the absorbed dose measured  
using film, ion chamber and the Profiler and the absorbed dose calculated by ADAC are 
acceptable.  If the point of measurement is in a highest dose area of the field, accurate 
measurement will be taken because most of the dose given in that point will be due to the 
primary beam. 
The horizontal and vertical profile trough point Q was also taken. The data 
obtained in each measurement by using films and the Profiler is shown in Appendix A.  
The plot of average profile given by film and the Profiler is shown in Figures 4.8, 4.9, 
4.10 and 4.11. 
 The plot given by the RIT113 system when using film dosimetry is also shown in 
Appendix B. (see Figures B.5, B.6, B.7 and B.8). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8.   Horizontal profile through point Q, field A.  The graph shows 
         the profile given by ADAC, film and Profiler. 
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Figure 4.9.   Vertical profile through point Q, field A.  The graph 
           shows the profile given by  ADAC, film and Profiler. 
Figure 4.10.   Horizontal profile through point Q, field B.  The graph  
           shows the profile given by ADAC, film and Profiler. 
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By comparing measurement of absorbed dose in point P and point Q, one can note that 
measurements taken in point Q are more accurate. The data measured by ion chamber, 
film and the Profiler and the data calculated by ADAC have more agreement  when 
measured in  point Q than when they are measured in point P. 
 The Profiler was also tested in a real IMRT case. The following example, a 
prostate case, was a real case whose first IMRT QA using film dosimetry was not as good 
as expected.  
 Table 4.10 shows the dose calculated by ADAC and the dose measured with film 
dosimetry for each field in the case. The point of measurement is shown in the map of 
dose rate distribution in Appendix C.    The vertical and horizontal profiles given by film 
dosimetry and the Profiler are shown in Appendix C.  Appendix C also shows the map of 
Figure 4.11.   Vertical profile through point Q, field B.  The graph 
            shows the profile given by ADAC, film and Profiler 
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the dose rate distribution, the isodose distribution, tables of the values of doses in profiles 
and the graphs given by RIT113 in film dosimetry. 
   
 
Field 
 
ADAC Dose 
cGy 
Film  Dose 
cGy 
% diff 
 
A 62.40 54.92 -11.99 
B 53.90 48.99 -9.11 
C 56.00 51.26 -8.46 
D 57.60 52.40 -9.03 
E 61.40 59.50 -3.09 
F 56.70 57.30 1.06 
G 62.20 61.50 -1.13 
 
 Four fields out of seven had a difference greater than 5%.   The measured of the 
dose for these four fields were repeated but this time, film, ion chamber and the Profiler 
were used.  The following data were collected. 
 
 
 
Field 
ADAC 
cGy 
Film 
cGy 
% diff 
 
Ion Cham. 
cGy 
% diff 
 
Profiler 
cGy % diff 
A 62.40 57.10 -8.49 62.14 -0.42 60.50 -3.04 
B 53.90 49.80 -7.61 49.25 -8.63 49.10 -8.91 
C 56.00 54.10 -3.39 55.18 -1.46 52.78 -5.75 
D 57.60 54.90 -4.69 54.92 -4.65 53.80 -6.60 
 
Table 4.10.   Absorbed dose given by ADAC and Absorbed dose measured 
          by using film dosimetry for each IMRT field in the case. 
Table 4.11  Absorbed dose measured by film, ion chamber and the Profiler for  the IMRT 
         case. % diff is the difference relative to ADAC 
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 Field B is not receiving the expected dose. Table 4.12 shows differences when 
comparing absorbed dose measured with ion chamber and the Profiler. 
 
 
Field 
 
Ion 
Cham. 
cGy 
Profiler 
cGy 
% diff 
 
A 62.14 60.50 -2.87 
B 49.25 49.10 -0.30 
C 55.18 52.78 -4.44 
D 54.92 53.80 -2.04 
 
For field B the absorbed dose measured with film and the Profiler is consistent 
with values measured with ion chamber. See Table 4.11.  Because we are using the ion 
chamber measurement as reference, the differences found with respect to the ADAC 
calculated dose do not seem to be due to the instruments used. 
Time   Consideration 
 A quick analysis of the time spent when collecting data with the Profiler and film 
can also be done.  This analysis is based on a average number of fields used in IMRT 
treatment (7 fields). When using film, the following step needs to be done: 
a) Irradiating the  films. It takes about 20 min in irradiating all the films plus the 
calibration film; 
b) Developing the films. It takes about 10 min running the film through the processor; 
c) Scanning the films.  It takes about 20 min in scanning the films and saving the 
image file; and 
Table 4.12.  Absorbed dose measured with ion chamber 
        and the  Profiler. 
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d) Analyzing the Film data. It takes about 60 min to compare the data measured using 
film dosimetry and the data calculated by ADAC. 
It sums a total of 110 min. Dividing the total time over the number of field, the time 
per field can be obtained. The normal number of fields in IMRT treatment is 7 fields.  
15.71 min per field is the average time needed to verify each field when using film 
dosimetry.  It doesn’t account the dosimetrist’s work  time when calculating the IMRT 
QA fields. 
  On the other hand, when using the Profiler, the following steps are needed: 
a) Setup the Profiler. It takes about 5 min in connecting the Profiler to the computer 
and accessories; 
b) Irradiation time. It takes about 20 min to deliver the IMRT fields to the diode 
array. However, it needs to be done twice because vertical and horizontal profiles 
data need to be collected. It means that the total time in this step is about 40 min; 
and 
c) Analyzing the Data. The data collected by the Profiler can be analyzed 
immediately after irradiation. It can be done even after irradiating each film.  As 
mentioned in Appendix D, if all the instruction needed to do the comparison are 
stored in a macro, the analysis can be done just by clicking a key.  It shouldn’t 
take more than 15 min in analyzing all the fields. 
The total time is about 60 min. It gives a time rate of   8.57 min per field. Other 
advantage is to have the analysis almost immediately. Any doubt, the beam delivery can 
be performed right after the analysis.      
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CHAPTER 5 
SUMMARY AND CONCLUSIONS 
 
In this project, the ion chamber has been used as reference. The absorbed dose 
measured using the ion chamber has been taken as the true absorbed dose delivered by 
the Clinac. Under these circumstances, the Profiler has shown to be a feasible instrument 
to be used as a QA instrument for IMRT cases. In fact, all measurements of absorbed 
dose using the Profiler have been within 5% of the dose measures with the ion chamber.  
The profiles obtained using the Profiler have also shown to be similar to those obtained 
using film dosimetry. Unfortunately, there is no definitive method to quantify the 
accuracy of the profiles. In fact, profiles obtained using film dosimetry are not analyzed 
quantitative, they are compared qualitatively to the profiles given by the ADAC 
computer. Of course, one can compare each diode, or position in the film along the 
Profile with the respective position in the dose distribution file given by ADAC but no all 
of the points will have a difference within 5% because of high gradient areas and shifting 
errors. In areas of high gradient, 1 mm away can give differences as high as 50%.  
Even though there is not a clear way to compare profiles quantitative, one can 
analyze each segment of the line describing dose profile in order to give a comparing 
analysis. Profiles given by the one-dimensional diode array show that their shape are 
similar to those given by film dosimetry. Appendix C shows the vertical and horizontal 
profiles of four fields in a real treatment planned for a prostate lesion.  The quality of 
profiles given by the Profiler looks similar to those given by film dosimetry.   
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As a conclusion, one-dimensional diodes array, the Profiler, can definitely be used 
as a tool for IMRT QA.  Absorbed dose measured using the Profiler have differences less 
than 5% when compared to the absorbed dose measured using ion chamber. Profiles 
given by the one dimension diodes array have the same quality than those given by film 
dosimetry. No substantial differences were observed in the shape of profiles.  
Of course, as any instrument, certain consideration need to be taken when using 
the Profiler for IMRT measurements: 1) the average of the two central diodes is the dose 
shown in the Profiler display. As it is shown in this project, when these diodes are in 
areas where the dose is mostly due to scattering, the dose measured will depend greatly 
on the position of the diodes.  Because we don’t know the sequence movement of the 
multi- leaf, there is no way to know the best position of the diodes array. We can not 
know actually what is the best position of the Profiler to measure the dose even if we 
would know the multi- leaf sequence movement.  So  when taking the horizontal and 
vertical profiles in the point of measurement ,  maybe two different reading will be 
display in the Profiler data dock. Just pick the value that is closer to the value given by 
the ion chamber (if using it) or the ones given by ADAC calculation; 2) A point in low 
gradient area should be chosen to measure the absorbed dose in order to avoid big 
differences in dose when measuring using either position of the diodes. Further, 
measurements present less fluctuation when they are done in low dose gradient areas; 3) 
Choose a point of relative high dose to measure the absorbed dose; and 4) The Profiler 
has 46 diodes with 23 diodes at each side of the center. Because the two central diodes 
are placed in the point of measurement, only 11.5 cm at each side of the center can be 
shaped in the profile. If the distance from the point of measurement to any border of the 
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field is greater than 11.5 cm, the profile will be cut off at 11.5 cm from the point of 
measurement. As mentioned before, the Profiler can be used for IMRT measurement if 
the above considerations are taken. The main objective of this project has been reached. 
One can say that positioning only one diode in the point of measurement can give an 
accurate measurement of the dose. Doing so, the reading displayed in the Profiler 
window would not be the exact reading of the point. Actually, it would be the dose at 2.5 
mm away from the diode. Unfortunately, the dose display in the Profiler window is not 
the dose due to only one diode. The idea in this project was to consider the Profiler as a 
whole and its window reading. A one-dimensional diode array can be used as a tool for 
IMRT QA. However, it can not substitute the film dosimetry because isodose distribution 
can not be obtained with it. A two dimension diode array (Mapcheck) is needed to have a 
complete quality assurance without using film dosimetry. 
This project can lead to further investigation of quality assurance in the IMRT 
process. By having two different ways to analyze doses in IMRT treatments, it is possible 
to have a more rigorous IMRT QA.  Taking a look to the Table 4.11, absorbed dose 
measured using film; ion chamber and the Profiler have differences of about 8% for field 
B when compared to values given by ADAC. Is it possible that the three instrument used 
were wrong? The most likely happening is that either the Clinac is not delivering what 
ADAC is telling it to deliver or the Clinac is actually delivering exactly what ADAC says 
but ADAC is not modeling properly.  With a proper quality assurance either case can be 
discovered and solved by using film dosimetry, ion chamber and the Profiler. Of course, 
this is an open topic for further research.   
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Position 
cm 
M1 
cGy 
M2 
cGy 
M3 
cGy 
M4 
cGy 
M5 
cGy 
AVE 
cGy 
STD 
cGy 
-7.5 3.32 2.89 3.83 3.37 3.02 3.29 0.36 
-7 5.65 5.43 6.24 5.91 5.28 5.70 0.38 
-6.5 10.5 10.27 12.86 12.08 10.3 11.20 1.19 
-6 15.07 14.11 15.44 15.34 14.62 14.92 0.55 
-5.5 21.28 19.22 24.6 23.73 20.22 21.81 2.29 
-5 42.77 42.92 49.38 46.9 42.04 44.80 3.19 
-4.5 48.72 49.93 50.13 48.76 47.6 49.03 1.03 
-4 47.54 48.63 48.56 47.26 46.24 47.65 0.99 
-3.5 46.46 47.96 47.7 46.94 45.44 46.90 1.01 
-3 45.33 46.64 45.75 45.02 43.8 45.31 1.04 
-2.5 34.7 36.13 32.33 32.92 32.97 33.81 1.57 
-2 27.1 27.38 25.84 25.6 25.6 26.30 0.87 
-1.5 29.35 29.69 29.74 29.11 26.15 28.81 1.51 
-1 30.21 30.98 30.97 30.39 27.46 30.00 1.46 
-0.5 32.36 30.69 32.62 31.71 30.25 31.53 1.03 
0 36.7 36.25 37.41 36.8 34.83 36.40 0.97 
0.5 37.11 37.09 37.5 36.67 35.03 36.68 0.97 
1 34.29 34.58 34.05 33.84 32.67 33.89 0.73 
1.5 30.27 30.79 29.31 28.72 27.69 29.36 1.23 
2 25.41 25.43 25.05 25.42 24.99 25.26 0.22 
2.5 23.67 24.21 23.91 23.77 23.16 23.74 0.38 
3 20.99 22.28 20.9 21.19 19.75 21.02 0.90 
3.5 19.11 19.38 18.66 18.62 18.08 18.77 0.50 
4 17.09 17.36 17.02 17.25 17.04 17.15 0.15 
4.5 15.69 16.19 15.44 15.67 15.37 15.67 0.32 
5 13.94 14.71 13.89 14.13 13.5 14.03 0.44 
5.5 11.43 12.63 11.58 11.98 11.03 11.73 0.61 
6 9.19 10.06 8.97 9.44 8.74 9.28 0.51 
6.5 6.53 7.73 6.6 7.19 6.08 6.83 0.64 
Table A.1    Absorbed dose in horizontal profile in point P, Field A. 
         (film dosimetry). 
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Position 
cm 
M1 
cGy 
M2 
cGy 
M3 
cGy 
M4 
cGy 
M5 
cGy 
AVE 
cGy 
STD 
cGy 
10.5 7.55 4.52 6.01 5.5 7.37 6.19 1.28 
10 9.88 10.86 11.81 10.07 10.1 10.54 0.80 
9.5 15.66 12.63 14.81 13.56 16.24 14.58 1.48 
9 22.13 21.71 24.17 21.16 22.92 22.42 1.17 
8.5 28.09 25.83 29.83 25.7 27.46 27.38 1.71 
8 33.59 32.19 34.77 32.44 33.15 33.23 1.03 
7.5 36.89 36.9 38.34 36.57 35.8 36.90 0.92 
7 38.29 38.49 38.94 38.11 37.14 38.19 0.67 
6.5 42.65 40.28 41.34 40.29 41.29 41.17 0.97 
6 44.82 44.63 45.51 43.9 43.67 44.51 0.74 
5.5 40.43 45.37 45.47 43.35 38.96 42.72 2.93 
5 38.05 39.76 40.45 38.98 36.46 38.74 1.56 
4.5 39.54 38.94 40.14 38.9 37.61 39.03 0.94 
4 43.9 40.69 41.65 41.04 42.28 41.91 1.27 
3.5 44.82 45.39 44.99 44.18 42.98 44.47 0.94 
3 41.93 44.43 43.36 42.51 39.33 42.31 1.91 
2.5 32.9 38.41 36.3 35.58 30.75 34.79 3.00 
2 35.18 32.21 33.5 32.53 33.41 33.37 1.16 
1.5 35.28 35.87 35.82 35.39 33.38 35.15 1.02 
1 33.89 35.18 35.46 34.62 32.03 34.24 1.37 
0.5 35.57 33.88 35.44 34.73 33.75 34.67 0.85 
0 36.87 36.88 37.57 37.21 35.05 36.72 0.97 
-0.5 36.96 37.41 37.41 36.57 35.05 36.68 0.98 
-1 36.84 37.79 37.79 37.08 35.16 36.93 1.08 
-1.5 35.98 36.81 35.78 35.43 33.86 35.57 1.08 
-2 35.59 36.28 34.5 34.36 33.66 34.88 1.04 
-2.5 35.93 36.35 35.37 35.2 34.17 35.40 0.83 
-3 34.02 36.13 34.41 34.49 32.47 34.30 1.31 
-3.5 28.31 31.26 29 28.88 25.6 28.61 2.02 
-4 22.52 25.02 24 24.32 21.89 23.55 1.30 
-4.5 10.62 14.85 13.15 13.81 9.97 12.48 2.10 
 
 
 
 
 
 
 
 
 
 
Table A.2    Absorbed dose in vertical profile in point P, field A. 
         (film dosimetry). 
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Position 
cm 
M1 
cGy 
M2 
cGy 
M3 
cGy 
M4 
cGy 
M5 
cGy 
AVE 
cGy 
STD 
cGy 
-3 10.1 13.81 10.96 11.97 13.98 12.16 1.71 
-2.5 22.63 24.03 23.34 23.22 22.15 23.07 0.72 
-2 23.92 25.05 24.76 24.73 23.86 24.46 0.54 
-1.5 28.31 28.88 28.03 27.02 25.56 27.56 1.31 
-1 32.16 33.05 31.98 31.89 29.88 31.79 1.16 
-0.5 33.92 35.78 34.53 34.34 31.71 34.06 1.48 
0 33.98 35.61 34.6 34.41 31.74 34.07 1.43 
0.5 31.69 32.48 31.9 31.53 28.28 31.18 1.66 
1 27.93 28.05 27.76 26.84 25.65 27.25 1.01 
1.5 23.81 24.59 24.47 24.48 23 24.07 0.67 
2 21.78 22.38 21.83 21.92 20.32 21.65 0.78 
2.5 18.89 19.07 18.53 18.76 18.05 18.66 0.39 
3 17.27 17.69 17.59 17.75 17.32 17.52 0.22 
3.5 15.77 15.89 15.91 16.03 15.26 15.77 0.30 
4 15.17 15.33 15.14 15.17 14.74 15.11 0.22 
4.5 14.46 14.5 14.29 14.43 13.93 14.32 0.23 
5 13.52 13.67 13.56 13.48 13.05 13.46 0.24 
5.5 13.96 14.08 13.88 13.81 13.44 13.83 0.24 
6 14.17 14.29 14.08 14.12 13.98 14.13 0.11 
6.5 18.51 18.59 17.83 18.07 18.03 18.21 0.33 
7 20.37 20.21 19.24 19.45 18.17 19.49 0.88 
7.5 16.67 15.66 14.64 15.67 14.96 15.52 0.78 
8 15.86 14.31 12.31 14.18 13.88 14.11 1.26 
8.5 9.9 9.06 8.25 8.98 7.82 8.80 0.80 
9 7.46 6.73 5.91 6.7 6.41 6.64 0.56 
9.5 6.84 5.96 5.18 6.04 5.65 5.93 0.61 
10 4.57 4.49 4.44 4.57 3.9 4.39 0.28 
10.5 3.62 3.63 3.62 3.7 3.07 3.53 0.26 
11 3.02 3.11 3.2 3.05 2.53 2.98 0.26 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table A.3    Absorbed dose in horizontal profile in point P, field B. 
        (film dosimetry). 
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Position 
cm 
M1 
cGy 
M2 
cGy 
M3 
cGy 
M4 
cGy 
M5 
cGy 
AVE 
cGy 
STD 
cGy 
11 4.95 4.92 5.02 4.91 4.86 4.932 0.06 
10.5 9.6 10.97 10.96 10.18 10.11 10.364 0.59 
10 13.17 13.69 13.89 13.41 13.56 13.544 0.27 
9.5 21.91 23.93 23.67 22.92 22.77 23.04 0.80 
9 26.15 28.19 27.21 26.31 25.6 26.692 1.02 
8.5 31.36 32.97 31.79 31.41 29.84 31.474 1.12 
8 37.69 39.71 38.44 37.59 36.16 37.918 1.30 
7.5 40.22 41.24 39.9 39.93 38.06 39.87 1.15 
7 42.7 44.67 43.33 42.73 40.7 42.826 1.43 
6.5 42.96 45.35 43.38 43.01 41.12 43.164 1.51 
6 41.18 44.31 42.59 42.15 39.56 41.958 1.76 
5.5 40.27 42.47 40.79 40.59 37.94 40.412 1.62 
5 40 42.04 40.76 40.52 38.53 40.37 1.27 
4.5 41.4 42.85 41.7 41.29 39.45 41.338 1.22 
4 42.58 44.87 43.55 42.83 40.67 42.9 1.53 
3.5 40.89 43.81 41.94 41.19 38.26 41.218 2.01 
3 39.42 41.24 39.4 39.52 36.12 39.14 1.86 
2.5 38.96 41.08 39.09 38.96 36.16 38.85 1.75 
2 38.19 40.67 39.09 38.86 36.18 38.598 1.63 
1.5 37.86 40.19 38.73 38.47 35.9 38.23 1.56 
1 37.52 39.54 38.1 37.87 34.86 37.578 1.70 
0.5 35.3 37.98 36.33 35.71 32.69 35.602 1.92 
0 33.97 35.68 34.58 34.56 31.58 34.074 1.52 
-0.5 34.02 35.58 34.34 34.53 31.73 34.04 1.42 
-1 32.4 33.71 32.76 32.61 29.68 32.232 1.51 
-1.5 31.96 32.07 31.5 31.58 28.4 31.102 1.53 
-2 33.26 33.31 32.59 33.41 30.86 32.686 1.07 
-2.5 35.52 36.18 35.18 35.65 33.43 35.192 1.05 
-3 32.91 35.18 33.38 32.88 30.46 32.962 1.69 
-3.5 26.28 28.72 26.55 25.65 25.17 26.474 1.37 
-4 14.35 17.02 15.92 14.72 13.91 15.184 1.27 
 
 
 
 
 
 
 
 
 
 
 
Table A.4    Absorbed dose in vertical profile in point P, field B. 
          (film dosimetry). 
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Position 
cm 
M1 
cGy 
M2 
cGy 
M3 
cGy 
M4 
cGy 
M5 
cGy 
AVE 
cGy 
STD 
cGy 
-7.5 4.27 4.15 4.40 4.08 4.36 4.25 0.13 
-7 7.01 6.87 7.29 6.01 7.19 6.87 0.51 
-6.5 11.33 10.67 11.81 9.87 11.68 11.07 0.80 
-6 18.00 16.42 18.78 16.43 18.44 17.61 1.12 
-5.5 35.70 34.25 37.04 34.57 36.38 35.59 1.18 
-5 47.61 47.09 49.28 46.93 47.99 47.78 0.94 
-4.5 46.40 46.06 47.92 45.90 46.84 46.62 0.81 
-4 44.34 44.08 45.80 43.75 44.73 44.54 0.79 
-3.5 43.53 43.23 44.94 42.90 43.97 43.71 0.79 
-3 36.39 36.20 37.63 35.57 36.95 36.55 0.78 
-2.5 29.09 29.00 30.08 28.05 30.01 29.24 0.84 
-2 28.27 28.45 28.96 27.52 29.57 28.55 0.77 
-1.5 28.70 29.29 29.49 28.29 30.41 29.23 0.81 
-1 29.92 30.77 31.02 29.87 31.96 30.71 0.87 
-0.5 31.55 32.87 33.17 32.04 34.06 32.74 0.98 
0 32.85 34.27 34.69 33.51 35.59 34.18 1.06 
0.5 31.50 32.94 33.27 32.13 34.21 32.81 1.04 
1 28.61 29.90 30.08 28.96 31.03 29.72 0.96 
1.5 25.71 26.59 26.58 25.50 27.58 26.39 0.83 
2 23.42 24.07 23.97 22.89 25.00 23.87 0.79 
2.5 21.28 21.75 21.52 20.48 22.58 21.52 0.76 
3 20.13 20.47 20.24 19.19 21.32 20.27 0.76 
3.5 17.43 17.75 17.44 16.33 18.47 17.48 0.77 
4 15.54 15.86 15.64 14.43 16.47 15.59 0.74 
4.5 13.17 13.48 13.62 11.99 13.99 13.25 0.76 
5 10.09 10.42 10.67 8.77 10.76 10.14 0.81 
5.5 7.78 7.99 8.19 6.27 8.24 7.69 0.82 
6 5.65 5.74 5.88 4.34 5.92 5.50 0.66 
6.5 3.38 3.42 3.52 3.18 3.56 3.41 0.15 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table A.5    Absorbed dose in horizontal profile in point P, field A 
          (Profiler dosimetry). 
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Position 
cm 
M1 
cGy 
M2 
cGy 
M3 
cGy 
M4 
cGy 
M5 
cGy 
AVE 
cGy 
STD 
cGy 
10.5 7.81 7.89 6.97 6.65 8.19 7.50 0.66 
10 9.93 10.12 9.21 8.69 10.53 9.70 0.74 
9.5 19.92 21.21 21.60 20.09 22.22 21.01 0.99 
9 26.03 27.55 28.80 26.60 28.79 27.55 1.25 
8.5 30.19 31.72 33.47 30.85 33.10 31.87 1.41 
8 32.94 34.33 34.87 33.54 35.82 34.30 1.12 
7.5 34.11 35.52 35.88 34.80 37.06 35.48 1.12 
7 35.02 36.34 36.73 35.56 37.86 36.30 1.10 
6.5 38.41 39.56 40.38 38.93 41.22 39.70 1.12 
6 40.02 41.09 42.18 40.53 42.82 41.33 1.16 
5.5 35.06 36.45 36.87 35.70 37.98 36.41 1.12 
5 34.74 36.21 36.80 35.44 37.63 36.16 1.13 
4.5 35.51 36.92 37.53 36.17 38.36 36.90 1.12 
4 38.66 39.89 41.11 39.25 41.41 40.07 1.18 
3.5 38.99 40.25 41.58 39.62 41.81 40.45 1.22 
3 34.88 36.31 37.21 35.46 37.67 36.31 1.17 
2.5 29.59 31.35 33.15 30.39 32.51 31.40 1.47 
2 31.37 32.95 35.25 32.03 34.19 33.16 1.58 
1.5 31.13 32.73 35.09 31.85 34.00 32.96 1.60 
1 31.38 33.00 35.35 32.13 34.23 33.22 1.60 
0.5 32.49 33.95 34.84 33.14 35.26 33.94 1.15 
0 32.85 34.27 34.69 33.51 35.59 34.18 1.06 
-0.5 32.62 34.02 34.33 33.24 35.37 33.92 1.05 
-1 32.05 33.42 33.70 32.65 34.78 33.32 1.04 
-1.5 30.77 32.25 33.49 31.45 33.59 32.31 1.24 
-2 30.96 32.41 33.56 31.59 33.72 32.45 1.20 
-2.5 31.35 32.73 33.06 31.93 34.08 32.63 1.05 
-3 29.99 31.42 32.81 30.62 32.66 31.50 1.24 
-3.5 24.92 26.54 28.17 25.68 27.62 26.58 1.34 
-4 18.95 20.42 21.27 19.34 21.18 20.23 1.06 
-4.5 7.27 7.46 7.38 6.18 7.60 7.18 0.57 
 
 
 
 
 
 
 
 
 
 
Table A.6    Absorbed dose in vertical profile in point P, field A. 
         (Profiler dosimetry). 
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Position 
cm 
M1 
cGy 
M2 
cGy 
M3 
cGy 
M4 
cGy 
M5 
cGy 
AVE 
cGy 
STD 
cGy 
-3 5.69 5.62 5.73 5.65 6.22 5.78 0.25 
-2.5 21.62 21.54 21.70 21.75 23.94 22.11 1.03 
-2 25.22 25.22 25.35 25.46 27.98 25.84 1.20 
-1.5 28.24 28.27 28.42 28.55 31.31 28.96 1.32 
-1 31.07 31.15 31.25 31.34 33.66 31.69 1.10 
-0.5 33.16 33.23 33.30 33.46 34.09 33.45 0.38 
0 33.89 33.92 34.01 34.14 34.30 34.05 0.17 
0.5 32.80 32.86 32.98 33.06 34.02 33.14 0.50 
1 29.87 29.86 30.01 30.11 32.69 30.51 1.23 
1.5 26.88 26.91 27.01 27.09 29.72 27.52 1.23 
2 23.42 23.47 23.55 23.62 25.97 24.01 1.10 
2.5 20.98 21.02 21.09 21.17 23.27 21.50 0.99 
3 19.39 19.44 19.49 19.57 21.50 19.88 0.91 
3.5 16.84 16.88 16.91 16.98 18.68 17.26 0.80 
4 14.64 14.69 14.71 14.81 16.25 15.02 0.69 
4.5 13.80 13.86 13.88 13.96 15.32 14.17 0.65 
5 12.02 12.07 12.10 12.17 13.39 12.35 0.58 
5.5 11.31 11.32 11.35 11.38 12.54 11.58 0.54 
6 11.96 11.98 11.98 12.05 13.25 12.24 0.56 
6.5 14.19 14.20 14.24 14.32 15.78 14.55 0.69 
7 19.77 19.77 19.77 19.77 19.77 19.77 0.00 
7.5 18.77 18.84 18.80 18.96 20.83 19.24 0.89 
8 12.88 12.86 12.83 12.96 14.21 13.15 0.60 
8.5 10.50 10.50 10.48 10.60 11.61 10.74 0.49 
9 5.34 5.34 5.34 5.38 5.88 5.46 0.24 
9.5 4.18 4.18 4.18 4.22 4.59 4.27 0.18 
10 3.70 3.70 3.69 3.72 4.05 3.78 0.16 
10.5 2.51 2.52 2.51 2.54 2.74 2.56 0.10 
11 2.49 2.48 2.48 2.50 2.69 2.53 0.09 
 
 
 
 
 
 
 
 
 
 
 
Table A.7    Absorbed dose in horizontal profile in point P, field B. 
        (Profiler dosimetry). 
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Position 
cm 
M1 
cGy 
M2 
cGy 
M3 
cGy 
M4 cGy 
 
M5 
cGy 
AVE 
cGy 
STD 
cGy 
11 3.07 3.10 3.31 3.16 3.17 3.16 0.09 
10.5 7.79 7.82 8.45 7.91 7.96 7.99 0.27 
10 10.20 10.19 11.01 10.30 10.37 10.42 0.34 
9.5 22.24 22.27 24.02 22.37 22.53 22.69 0.75 
9 27.90 27.94 30.14 28.18 28.34 28.50 0.94 
8.5 31.29 31.37 33.51 31.61 31.80 31.91 0.91 
8 35.90 35.91 36.36 36.18 36.36 36.14 0.23 
7.5 37.51 37.58 37.73 37.83 38.02 37.73 0.20 
7 40.01 40.07 40.37 40.28 40.48 40.24 0.20 
6.5 40.64 40.68 40.97 40.90 41.07 40.85 0.19 
6 40.21 40.23 40.46 40.44 40.60 40.39 0.17 
5.5 38.29 38.35 38.37 38.57 38.71 38.46 0.17 
5 38.58 38.68 38.76 38.98 39.12 38.82 0.22 
4.5 38.74 38.81 38.91 39.06 39.21 38.95 0.19 
4 40.22 40.29 40.56 40.51 40.70 40.46 0.20 
3.5 40.16 40.24 40.55 40.53 40.69 40.44 0.23 
3 37.40 37.46 37.47 37.67 37.82 37.56 0.18 
2.5 36.83 36.92 36.90 37.08 37.27 37.00 0.18 
2 36.48 36.53 36.56 36.72 36.90 36.64 0.17 
1.5 36.11 36.17 36.20 36.38 36.51 36.27 0.16 
1 36.41 36.51 36.66 36.77 36.90 36.65 0.20 
0.5 35.38 35.46 35.59 35.67 35.84 35.59 0.18 
0 33.89 33.92 34.01 34.14 34.30 34.05 0.17 
-0.5 33.42 33.50 33.57 33.69 33.83 33.60 0.16 
-1 32.86 32.89 33.03 33.02 33.18 32.99 0.13 
-1.5 31.50 31.53 32.87 31.65 31.80 31.87 0.57 
-2 31.66 31.69 32.96 31.82 31.96 32.02 0.54 
-2.5 33.20 33.21 33.31 33.38 33.52 33.32 0.13 
-3 34.42 34.47 34.73 34.68 34.80 34.62 0.17 
-3.5 31.28 31.32 31.82 31.49 31.61 31.50 0.22 
-4 25.09 25.13 27.34 25.33 25.44 25.67 0.95 
-4.5 11.12 11.16 12.19 11.32 11.36 11.43 0.44 
Table A.8    Absorbed dose in vertical profile in point P, field B. 
        (Profiler dosimetry). 
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  -7.5 -7 -6.5 -6 -5.5 -5 -4.5 -4 -3.5 -3 
-9.5 0.020 0.024 0.025 0.025 0.027 0.028 0.029 0.030 0.031 0.031 
-9 0.020 0.025 0.025 0.026 0.028 0.030 0.031 0.033 0.033 0.033 
-8.5 0.021 0.025 0.026 0.028 0.037 0.045 0.047 0.047 0.045 0.045 
-8 0.022 0.026 0.027 0.031 0.059 0.084 0.084 0.083 0.077 0.075 
-7.5 0.024 0.029 0.031 0.038 0.081 0.113 0.108 0.111 0.113 0.111 
-7 0.032 0.048 0.051 0.063 0.100 0.117 0.122 0.148 0.169 0.161 
-6.5 0.053 0.095 0.104 0.111 0.127 0.133 0.164 0.221 0.252 0.236 
-6 0.066 0.127 0.141 0.149 0.152 0.171 0.230 0.289 0.305 0.289 
-5.5 0.062 0.125 0.142 0.147 0.163 0.203 0.275 0.315 0.321 0.296 
-5 0.047 0.100 0.125 0.125 0.155 0.212 0.290 0.329 0.335 0.297 
-4.5 0.040 0.083 0.108 0.112 0.146 0.208 0.296 0.361 0.373 0.325 
-4 0.034 0.068 0.091 0.097 0.127 0.182 0.295 0.400 0.413 0.373 
-3.5 0.028 0.045 0.060 0.065 0.090 0.143 0.282 0.418 0.426 0.389 
-3 0.025 0.033 0.039 0.044 0.063 0.130 0.297 0.422 0.417 0.362 
-2.5 0.025 0.031 0.035 0.042 0.074 0.174 0.347 0.428 0.416 0.359 
-2 0.026 0.032 0.037 0.054 0.142 0.282 0.411 0.436 0.428 0.386 
-1.5 0.027 0.033 0.039 0.079 0.221 0.365 0.442 0.439 0.433 0.395 
-1 0.028 0.034 0.042 0.084 0.234 0.382 0.443 0.436 0.422 0.378 
-0.5 0.028 0.039 0.054 0.093 0.235 0.369 0.418 0.409 0.383 0.329 
0 0.028 0.048 0.075 0.115 0.245 0.353 0.369 0.357 0.339 0.292 
0.5 0.028 0.052 0.086 0.131 0.256 0.348 0.348 0.333 0.321 0.282 
1 0.028 0.052 0.086 0.139 0.265 0.353 0.355 0.338 0.323 0.283 
1.5 0.032 0.056 0.086 0.147 0.283 0.371 0.387 0.357 0.331 0.288 
2 0.042 0.073 0.088 0.147 0.289 0.385 0.418 0.384 0.347 0.296 
2.5 0.049 0.080 0.087 0.132 0.242 0.340 0.402 0.418 0.377 0.313 
3 0.037 0.054 0.072 0.117 0.177 0.249 0.346 0.422 0.417 0.345 
3.5 0.027 0.035 0.055 0.096 0.121 0.160 0.247 0.349 0.403 0.365 
4 0.023 0.029 0.039 0.064 0.082 0.098 0.147 0.233 0.317 0.316 
4.5 0.019 0.022 0.025 0.033 0.045 0.056 0.086 0.134 0.194 0.212 
5 0.011 0.013 0.014 0.016 0.020 0.025 0.038 0.054 0.074 0.083 
5.5 0.007 0.007 0.008 0.009 0.011 0.013 0.016 0.018 0.021 0.022 
6 0.006 0.006 0.006 0.007 0.009 0.010 0.011 0.012 0.013 0.012 
6.5 0.005 0.006 0.006 0.006 0.008 0.009 0.010 0.010 0.011 0.010 
7 0.005 0.005 0.005 0.005 0.007 0.008 0.008 0.009 0.009 0.008 
7.5 0.004 0.005 0.005 0.005 0.006 0.007 0.007 0.008 0.008 0.007 
8 0.004 0.004 0.004 0.004 0.005 0.006 0.007 0.007 0.007 0.006 
8.5 0.004 0.004 0.004 0.004 0.005 0.005 0.006 0.006 0.006 0.006 
9 0.003 0.003 0.003 0.003 0.004 0.005 0.005 0.006 0.006 0.005 
9.5 0.003 0.003 0.003 0.003 0.004 0.004 0.005 0.005 0.005 0.005 
10 0.003 0.002 0.002 0.002 0.003 0.004 0.004 0.005 0.005 0.004 
 
 
Table A.9a  Dose rate (cGy/MU) distribution for field A.  The dose rate is  
                    the average for each 5x5 mm area.  (values for  X=-7.5  to X=-3 ). 
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  -2.5 -2 -1.5 -1 -0.5 0 0.5 1 1.5 2 2.5 
-9.5 0.030 0.031 0.032 0.036 0.053 0.102 0.186 0.262 0.298 0.305 0.281 
-9 0.033 0.033 0.036 0.049 0.086 0.150 0.232 0.288 0.302 0.290 0.261 
-8.5 0.044 0.042 0.047 0.076 0.132 0.194 0.248 0.276 0.276 0.260 0.239 
-8 0.074 0.072 0.082 0.123 0.181 0.231 0.256 0.263 0.257 0.243 0.232 
-7.5 0.108 0.116 0.142 0.174 0.213 0.247 0.265 0.271 0.271 0.264 0.254 
-7 0.150 0.159 0.191 0.211 0.233 0.260 0.279 0.297 0.309 0.300 0.288 
-6.5 0.218 0.206 0.228 0.239 0.259 0.283 0.305 0.332 0.344 0.326 0.312 
-6 0.260 0.228 0.240 0.246 0.265 0.291 0.319 0.344 0.347 0.326 0.312 
-5.5 0.246 0.218 0.227 0.228 0.242 0.269 0.296 0.314 0.318 0.307 0.297 
-5 0.237 0.215 0.224 0.218 0.225 0.249 0.273 0.286 0.297 0.293 0.278 
-4.5 0.262 0.240 0.246 0.236 0.241 0.258 0.273 0.283 0.294 0.291 0.274 
-4 0.302 0.268 0.270 0.265 0.274 0.283 0.289 0.292 0.293 0.290 0.273 
-3.5 0.320 0.279 0.279 0.273 0.283 0.290 0.295 0.295 0.286 0.278 0.261 
-3 0.318 0.276 0.274 0.264 0.264 0.268 0.277 0.280 0.269 0.257 0.237 
-2.5 0.314 0.265 0.260 0.246 0.242 0.241 0.253 0.264 0.255 0.234 0.211 
-2 0.312 0.255 0.251 0.237 0.233 0.235 0.247 0.256 0.245 0.217 0.195 
-1.5 0.303 0.250 0.249 0.234 0.229 0.235 0.247 0.247 0.232 0.205 0.185 
-1 0.288 0.242 0.243 0.227 0.222 0.232 0.243 0.237 0.217 0.198 0.180 
-0.5 0.254 0.225 0.230 0.219 0.221 0.239 0.244 0.230 0.209 0.190 0.176 
0 0.223 0.206 0.217 0.216 0.227 0.248 0.245 0.228 0.205 0.185 0.171 
0.5 0.211 0.196 0.210 0.219 0.238 0.251 0.243 0.222 0.201 0.180 0.160 
1 0.208 0.189 0.205 0.224 0.248 0.250 0.238 0.212 0.194 0.171 0.148 
1.5 0.210 0.187 0.204 0.224 0.250 0.249 0.232 0.204 0.183 0.161 0.136 
2 0.220 0.191 0.204 0.225 0.249 0.248 0.232 0.201 0.171 0.142 0.118 
2.5 0.236 0.202 0.210 0.227 0.248 0.247 0.233 0.198 0.156 0.118 0.091 
3 0.255 0.215 0.215 0.226 0.240 0.239 0.222 0.185 0.140 0.101 0.074 
3.5 0.269 0.218 0.207 0.206 0.214 0.212 0.195 0.165 0.132 0.103 0.079 
4 0.237 0.199 0.183 0.160 0.162 0.155 0.143 0.126 0.107 0.093 0.083 
4.5 0.163 0.144 0.129 0.086 0.080 0.075 0.067 0.061 0.055 0.051 0.049 
5 0.066 0.062 0.053 0.034 0.030 0.028 0.024 0.023 0.022 0.021 0.021 
5.5 0.019 0.018 0.017 0.015 0.014 0.013 0.012 0.012 0.011 0.011 0.010 
6 0.010 0.010 0.011 0.011 0.011 0.010 0.010 0.009 0.009 0.009 0.009 
6.5 0.008 0.007 0.008 0.008 0.009 0.009 0.009 0.008 0.008 0.008 0.007 
7 0.007 0.006 0.006 0.007 0.007 0.008 0.008 0.008 0.007 0.007 0.007 
7.5 0.006 0.005 0.005 0.005 0.006 0.007 0.007 0.007 0.007 0.006 0.006 
8 0.005 0.004 0.004 0.004 0.005 0.006 0.006 0.007 0.007 0.006 0.005 
8.5 0.004 0.004 0.004 0.004 0.004 0.005 0.005 0.006 0.006 0.006 0.005 
9 0.004 0.003 0.004 0.004 0.004 0.004 0.004 0.005 0.005 0.005 0.005 
9.5 0.004 0.003 0.003 0.003 0.004 0.004 0.004 0.004 0.004 0.005 0.005 
10 0.003 0.003 0.003 0.003 0.003 0.003 0.004 0.004 0.004 0.004 0.004 
 
 
 
Table A.9b  Dose rate (cGy/MU) distribution for field A.  The dose rate is  
                    the average for each 5x5 mm area.  (values for  X=-2.5  to X=2.5 ). 
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  3 3.5 4 4.5 5 5.5 6 6.5 7 7.5 8 
-9.5 0.250 0.226 0.210 0.197 0.179 0.151 0.109 0.060 0.017 0.009 0.007 
-9 0.237 0.218 0.211 0.198 0.177 0.148 0.099 0.052 0.016 0.009 0.007 
-8.5 0.224 0.215 0.212 0.198 0.174 0.134 0.076 0.040 0.015 0.009 0.008 
-8 0.223 0.217 0.213 0.199 0.168 0.111 0.056 0.033 0.014 0.009 0.008 
-7.5 0.243 0.227 0.218 0.200 0.159 0.093 0.051 0.032 0.015 0.010 0.008 
-7 0.275 0.255 0.236 0.205 0.160 0.094 0.060 0.035 0.015 0.011 0.009 
-6.5 0.298 0.279 0.252 0.213 0.177 0.114 0.084 0.049 0.018 0.012 0.010 
-6 0.297 0.279 0.247 0.215 0.188 0.139 0.115 0.072 0.022 0.012 0.010 
-5.5 0.283 0.261 0.234 0.212 0.193 0.161 0.140 0.088 0.025 0.013 0.010 
-5 0.264 0.243 0.220 0.203 0.187 0.169 0.147 0.091 0.025 0.012 0.010 
-4.5 0.253 0.236 0.215 0.196 0.182 0.171 0.151 0.089 0.025 0.012 0.010 
-4 0.254 0.238 0.221 0.199 0.183 0.172 0.153 0.090 0.025 0.012 0.010 
-3.5 0.246 0.234 0.219 0.198 0.180 0.165 0.149 0.088 0.024 0.012 0.010 
-3 0.221 0.213 0.201 0.182 0.167 0.151 0.138 0.083 0.023 0.012 0.009 
-2.5 0.197 0.188 0.175 0.159 0.151 0.139 0.126 0.077 0.021 0.011 0.009 
-2 0.184 0.172 0.155 0.146 0.140 0.127 0.110 0.068 0.020 0.011 0.009 
-1.5 0.177 0.162 0.145 0.139 0.130 0.110 0.091 0.056 0.018 0.010 0.008 
-1 0.170 0.151 0.137 0.126 0.114 0.094 0.080 0.050 0.016 0.010 0.008 
-0.5 0.164 0.142 0.127 0.115 0.097 0.084 0.071 0.041 0.014 0.009 0.008 
0 0.158 0.138 0.120 0.107 0.087 0.072 0.056 0.034 0.013 0.009 0.008 
0.5 0.146 0.131 0.111 0.093 0.075 0.057 0.042 0.027 0.012 0.008 0.007 
1 0.133 0.118 0.098 0.077 0.060 0.043 0.032 0.023 0.011 0.008 0.007 
1.5 0.120 0.103 0.080 0.064 0.051 0.037 0.028 0.021 0.011 0.008 0.007 
2 0.102 0.084 0.065 0.054 0.044 0.034 0.028 0.021 0.011 0.007 0.007 
2.5 0.075 0.063 0.053 0.044 0.037 0.032 0.031 0.022 0.010 0.007 0.006 
3 0.060 0.050 0.045 0.042 0.042 0.037 0.036 0.022 0.010 0.007 0.006 
3.5 0.067 0.062 0.062 0.066 0.069 0.051 0.032 0.021 0.010 0.006 0.006 
4 0.085 0.093 0.101 0.103 0.096 0.068 0.030 0.020 0.009 0.006 0.006 
4.5 0.060 0.071 0.084 0.095 0.084 0.060 0.025 0.016 0.008 0.005 0.005 
5 0.024 0.028 0.035 0.041 0.037 0.027 0.014 0.009 0.005 0.004 0.004 
5.5 0.011 0.011 0.011 0.011 0.011 0.009 0.007 0.005 0.004 0.004 0.003 
6 0.008 0.008 0.008 0.008 0.007 0.007 0.006 0.005 0.004 0.003 0.003 
6.5 0.007 0.007 0.007 0.007 0.006 0.006 0.005 0.004 0.004 0.003 0.003 
7 0.006 0.006 0.006 0.006 0.006 0.005 0.005 0.004 0.004 0.003 0.003 
7.5 0.006 0.006 0.006 0.006 0.005 0.005 0.005 0.004 0.003 0.003 0.003 
8 0.005 0.005 0.005 0.005 0.005 0.005 0.004 0.004 0.003 0.003 0.003 
8.5 0.005 0.005 0.005 0.005 0.005 0.004 0.004 0.003 0.003 0.003 0.003 
9 0.005 0.005 0.004 0.004 0.004 0.004 0.004 0.003 0.003 0.003 0.003 
9.5 0.005 0.004 0.004 0.004 0.004 0.004 0.003 0.003 0.003 0.002 0.002 
10 0.004 0.004 0.004 0.004 0.004 0.003 0.003 0.003 0.002 0.002 0.002 
 
 
 
 
 
Table A.9c  Dose rate (cGy/MU) distribution for field A.  The dose rate is  
                    the average for each 5x5 mm area.  (values for  X=3  to X=8 ). 
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  -7.5 -7 -6.5 -6 -5.5 -5 -4.5 -4 -3.5 -3 
-9.5 0.005 0.006 0.006 0.006 0.007 0.007 0.008 0.009 0.010 0.014 
-9 0.005 0.006 0.006 0.006 0.007 0.007 0.008 0.009 0.011 0.015 
-8.5 0.005 0.006 0.006 0.006 0.007 0.008 0.008 0.009 0.011 0.020 
-8 0.005 0.006 0.006 0.007 0.007 0.008 0.009 0.010 0.013 0.030 
-7.5 0.006 0.006 0.007 0.007 0.008 0.008 0.009 0.011 0.014 0.041 
-7 0.006 0.006 0.007 0.007 0.008 0.009 0.010 0.012 0.015 0.049 
-6.5 0.006 0.007 0.007 0.008 0.009 0.010 0.011 0.013 0.017 0.056 
-6 0.006 0.007 0.007 0.008 0.009 0.010 0.011 0.013 0.019 0.059 
-5.5 0.006 0.007 0.007 0.008 0.009 0.010 0.012 0.014 0.020 0.060 
-5 0.006 0.007 0.007 0.008 0.009 0.010 0.012 0.015 0.021 0.060 
-4.5 0.006 0.007 0.007 0.008 0.009 0.011 0.013 0.016 0.022 0.063 
-4 0.006 0.007 0.007 0.008 0.010 0.012 0.014 0.017 0.023 0.066 
-3.5 0.006 0.007 0.008 0.009 0.010 0.012 0.015 0.017 0.023 0.065 
-3 0.006 0.007 0.008 0.009 0.011 0.013 0.015 0.017 0.023 0.066 
-2.5 0.006 0.007 0.008 0.009 0.011 0.013 0.015 0.017 0.022 0.065 
-2 0.006 0.007 0.008 0.010 0.011 0.013 0.015 0.017 0.022 0.065 
-1.5 0.006 0.007 0.008 0.010 0.011 0.013 0.014 0.017 0.022 0.063 
-1 0.006 0.008 0.009 0.010 0.011 0.013 0.015 0.017 0.022 0.063 
-0.5 0.006 0.007 0.008 0.009 0.011 0.012 0.014 0.016 0.021 0.061 
0 0.006 0.007 0.008 0.009 0.010 0.012 0.013 0.016 0.020 0.058 
0.5 0.006 0.007 0.008 0.009 0.010 0.011 0.013 0.015 0.020 0.055 
1 0.006 0.007 0.007 0.008 0.009 0.011 0.012 0.014 0.019 0.056 
1.5 0.006 0.006 0.007 0.008 0.009 0.010 0.012 0.014 0.018 0.054 
2 0.006 0.006 0.007 0.008 0.008 0.010 0.011 0.013 0.017 0.056 
2.5 0.006 0.007 0.007 0.008 0.008 0.009 0.010 0.012 0.017 0.057 
3 0.006 0.007 0.007 0.008 0.008 0.009 0.010 0.012 0.017 0.059 
3.5 0.006 0.007 0.007 0.008 0.008 0.009 0.010 0.011 0.016 0.061 
4 0.006 0.006 0.007 0.007 0.008 0.008 0.009 0.011 0.015 0.062 
4.5 0.005 0.006 0.006 0.006 0.006 0.007 0.008 0.009 0.013 0.046 
5 0.004 0.005 0.005 0.005 0.005 0.006 0.006 0.008 0.010 0.024 
5.5 0.004 0.004 0.004 0.004 0.005 0.005 0.006 0.007 0.008 0.010 
6 0.004 0.004 0.004 0.004 0.005 0.005 0.006 0.006 0.007 0.007 
6.5 0.004 0.004 0.004 0.004 0.005 0.005 0.006 0.006 0.005 0.006 
7 0.004 0.004 0.004 0.004 0.005 0.005 0.005 0.005 0.004 0.005 
7.5 0.004 0.004 0.004 0.004 0.005 0.004 0.004 0.004 0.004 0.004 
8 0.004 0.004 0.004 0.004 0.004 0.004 0.004 0.003 0.003 0.003 
8.5 0.004 0.004 0.004 0.004 0.004 0.003 0.003 0.003 0.002 0.003 
9 0.004 0.004 0.004 0.003 0.003 0.003 0.002 0.002 0.002 0.003 
9.5 0.003 0.003 0.003 0.003 0.003 0.002 0.002 0.002 0.002 0.002 
10 0.003 0.003 0.003 0.003 0.002 0.002 0.002 0.002 0.002 0.002 
 
Table A.10a  Dose rate (cGy/MU) distribution for field B.  The dose rate is the 
                        average for each 5x5 mm area.  (values for  X=-7.5  to X=-3 ). 
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  -2.5 -2 -1.5 -1 -0.5 0 0.5 1 1.5 2 2.5 
-9.5 0.028 0.034 0.036 0.047 0.082 0.150 0.255 0.349 0.388 0.403 0.381 
-9 0.031 0.037 0.043 0.072 0.136 0.218 0.316 0.379 0.395 0.393 0.366 
-8.5 0.050 0.058 0.066 0.114 0.193 0.276 0.348 0.382 0.382 0.371 0.347 
-8 0.101 0.116 0.123 0.180 0.263 0.337 0.379 0.389 0.376 0.360 0.344 
-7.5 0.151 0.181 0.199 0.250 0.321 0.381 0.403 0.406 0.396 0.377 0.362 
-7 0.189 0.237 0.261 0.300 0.353 0.402 0.424 0.428 0.422 0.403 0.388 
-6.5 0.219 0.279 0.296 0.325 0.372 0.410 0.436 0.442 0.439 0.424 0.405 
-6 0.234 0.291 0.306 0.328 0.372 0.406 0.435 0.444 0.444 0.432 0.408 
-5.5 0.221 0.281 0.305 0.323 0.361 0.394 0.425 0.443 0.442 0.428 0.403 
-5 0.219 0.281 0.311 0.325 0.358 0.387 0.419 0.439 0.433 0.414 0.395 
-4.5 0.237 0.300 0.327 0.342 0.368 0.390 0.422 0.439 0.427 0.407 0.391 
-4 0.250 0.318 0.341 0.359 0.378 0.401 0.428 0.438 0.427 0.402 0.383 
-3.5 0.254 0.324 0.346 0.365 0.382 0.405 0.424 0.430 0.417 0.389 0.362 
-3 0.250 0.320 0.340 0.358 0.376 0.395 0.406 0.408 0.397 0.365 0.334 
-2.5 0.245 0.313 0.333 0.344 0.362 0.381 0.394 0.396 0.381 0.342 0.314 
-2 0.244 0.308 0.329 0.337 0.356 0.373 0.390 0.390 0.369 0.324 0.294 
-1.5 0.241 0.306 0.327 0.331 0.349 0.370 0.386 0.382 0.349 0.303 0.274 
-1 0.240 0.301 0.320 0.327 0.344 0.367 0.381 0.370 0.330 0.291 0.262 
-0.5 0.235 0.293 0.307 0.320 0.340 0.362 0.369 0.352 0.314 0.281 0.252 
0 0.219 0.280 0.294 0.313 0.341 0.357 0.352 0.330 0.296 0.263 0.237 
0.5 0.208 0.260 0.279 0.311 0.346 0.354 0.343 0.314 0.278 0.243 0.216 
1 0.205 0.249 0.270 0.312 0.350 0.351 0.333 0.299 0.258 0.222 0.193 
1.5 0.206 0.254 0.276 0.315 0.350 0.348 0.322 0.289 0.246 0.206 0.173 
2 0.219 0.270 0.292 0.326 0.356 0.351 0.321 0.284 0.236 0.188 0.154 
2.5 0.225 0.286 0.313 0.345 0.368 0.364 0.333 0.281 0.227 0.171 0.135 
3 0.239 0.302 0.331 0.358 0.368 0.366 0.339 0.280 0.220 0.156 0.119 
3.5 0.255 0.316 0.332 0.343 0.343 0.340 0.318 0.270 0.218 0.159 0.117 
4 0.259 0.311 0.311 0.301 0.273 0.265 0.246 0.217 0.180 0.142 0.112 
4.5 0.191 0.230 0.231 0.211 0.148 0.139 0.128 0.107 0.092 0.081 0.071 
5 0.078 0.093 0.092 0.084 0.052 0.048 0.045 0.038 0.035 0.033 0.031 
5.5 0.020 0.023 0.023 0.022 0.019 0.018 0.018 0.016 0.016 0.015 0.015 
6 0.011 0.012 0.012 0.012 0.012 0.013 0.013 0.013 0.012 0.012 0.011 
6.5 0.009 0.010 0.010 0.010 0.010 0.011 0.011 0.011 0.011 0.010 0.010 
7 0.008 0.008 0.008 0.009 0.009 0.009 0.010 0.010 0.010 0.009 0.008 
7.5 0.007 0.007 0.007 0.008 0.008 0.008 0.009 0.009 0.008 0.008 0.007 
8 0.006 0.007 0.007 0.007 0.007 0.008 0.008 0.007 0.007 0.007 0.006 
8.5 0.005 0.006 0.006 0.007 0.007 0.007 0.007 0.006 0.006 0.005 0.005 
9 0.005 0.006 0.006 0.006 0.006 0.006 0.006 0.006 0.005 0.005 0.004 
9.5 0.004 0.005 0.005 0.006 0.006 0.006 0.005 0.005 0.005 0.004 0.004 
10 0.004 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.004 0.004 0.003 
 
 
Table A.10b  Dose rate (cGy/MU) distribution for field B.  The dose rate is the  
                       average for each 5x5 mm area.  (values for  X=-2.5  to X=2.5 ). 
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 3 3.5 4 4.5 5 5.5 6 6.5 7 7.5 8 
-9.5 0.351 0.323 0.306 0.302 0.293 0.255 0.210 0.141 0.052 0.034 0.031 
-9 0.337 0.316 0.308 0.305 0.296 0.251 0.193 0.125 0.050 0.034 0.031 
-8.5 0.324 0.312 0.309 0.305 0.289 0.236 0.168 0.108 0.048 0.035 0.032 
-8 0.323 0.314 0.311 0.299 0.271 0.214 0.151 0.101 0.048 0.036 0.034 
-7.5 0.340 0.324 0.316 0.298 0.259 0.198 0.143 0.100 0.051 0.040 0.037 
-7 0.368 0.351 0.331 0.303 0.263 0.204 0.154 0.111 0.082 0.070 0.057 
-6.5 0.389 0.369 0.342 0.311 0.282 0.229 0.190 0.179 0.177 0.161 0.119 
-6 0.391 0.365 0.334 0.310 0.291 0.253 0.230 0.252 0.274 0.263 0.197 
-5.5 0.376 0.343 0.318 0.299 0.282 0.263 0.253 0.295 0.323 0.314 0.263 
-5 0.360 0.323 0.305 0.282 0.273 0.266 0.260 0.303 0.337 0.329 0.295 
-4.5 0.354 0.316 0.299 0.275 0.271 0.269 0.263 0.300 0.338 0.330 0.300 
-4 0.348 0.313 0.297 0.273 0.270 0.270 0.264 0.299 0.338 0.328 0.292 
-3.5 0.330 0.307 0.288 0.266 0.262 0.260 0.256 0.295 0.336 0.322 0.276 
-3 0.310 0.293 0.271 0.252 0.241 0.235 0.235 0.284 0.325 0.312 0.266 
-2.5 0.290 0.271 0.251 0.232 0.218 0.211 0.210 0.255 0.294 0.290 0.256 
-2 0.270 0.250 0.232 0.214 0.202 0.192 0.187 0.225 0.263 0.269 0.256 
-1.5 0.253 0.232 0.214 0.198 0.186 0.167 0.166 0.201 0.242 0.259 0.269 
-1 0.240 0.216 0.198 0.179 0.164 0.146 0.148 0.185 0.234 0.257 0.275 
-0.5 0.223 0.198 0.177 0.160 0.150 0.135 0.138 0.177 0.230 0.251 0.263 
0 0.208 0.183 0.159 0.147 0.141 0.131 0.134 0.170 0.222 0.230 0.217 
0.5 0.192 0.171 0.147 0.133 0.124 0.121 0.129 0.156 0.187 0.168 0.122 
1 0.169 0.148 0.132 0.109 0.096 0.101 0.121 0.121 0.107 0.087 0.055 
1.5 0.147 0.127 0.112 0.088 0.082 0.090 0.112 0.091 0.055 0.043 0.035 
2 0.132 0.116 0.097 0.078 0.079 0.088 0.097 0.064 0.039 0.033 0.031 
2.5 0.113 0.100 0.079 0.067 0.078 0.096 0.089 0.045 0.033 0.030 0.029 
3 0.091 0.082 0.069 0.065 0.090 0.114 0.087 0.039 0.031 0.029 0.028 
3.5 0.089 0.083 0.084 0.103 0.137 0.130 0.068 0.034 0.029 0.028 0.028 
4 0.094 0.092 0.111 0.154 0.183 0.144 0.052 0.030 0.028 0.027 0.027 
4.5 0.066 0.067 0.097 0.147 0.163 0.125 0.041 0.024 0.023 0.023 0.022 
5 0.030 0.030 0.043 0.063 0.069 0.052 0.021 0.014 0.014 0.013 0.013 
5.5 0.014 0.014 0.014 0.015 0.016 0.014 0.010 0.009 0.009 0.008 0.008 
6 0.011 0.010 0.009 0.009 0.009 0.008 0.008 0.008 0.008 0.007 0.007 
6.5 0.009 0.008 0.008 0.008 0.007 0.007 0.007 0.007 0.007 0.007 0.006 
7 0.007 0.007 0.007 0.007 0.007 0.006 0.006 0.006 0.006 0.006 0.006 
7.5 0.006 0.006 0.006 0.006 0.006 0.006 0.005 0.006 0.006 0.006 0.005 
8 0.005 0.005 0.005 0.005 0.006 0.005 0.005 0.005 0.005 0.005 0.005 
8.5 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005 
9 0.004 0.004 0.004 0.004 0.005 0.004 0.004 0.005 0.005 0.005 0.004 
9.5 0.004 0.004 0.004 0.004 0.004 0.004 0.004 0.004 0.004 0.004 0.004 
10 0.003 0.003 0.004 0.004 0.004 0.004 0.004 0.004 0.004 0.004 0.004 
 
 
Table A.10c  Dose rate (cGy/MU) distribution for field B.  The dose rate is the  
                      average for each 5x5 mm area.  (values for  X=3  to X=8 ). 
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Position 
cm 
M1 
cGy 
M2 
cGy 
M3 
cGy 
M4 
cGy 
M5 
cGy 
AVE 
cGy 
STD 
cGy 
-7.5 3.12 2.78 2.99 3.36 3.38 3.13 0.25 
-7 5.11 4.77 4.91 4.94 5.07 4.96 0.14 
-6.5 6.49 6.07 6.08 6.2 6.31 6.23 0.18 
-6 9.77 9.03 8.7 9.59 9.27 9.27 0.43 
-5.5 16.84 15.49 14.74 16.29 15.62 15.80 0.80 
-5 46.56 39.48 34.13 43.69 39.45 40.66 4.73 
-4.5 61.33 54.36 55.01 57.99 56.9 57.12 2.77 
-4 62.42 58.79 60.97 60.82 62.13 61.03 1.43 
-3.5 61.62 58.65 60.03 59.37 60.75 60.08 1.16 
-3 50.87 48.67 52.76 48.99 51.82 50.62 1.77 
-2.5 43.75 42.32 45.57 42.56 44.84 43.81 1.41 
-2 34.19 32.33 35.22 32.99 35.18 33.98 1.30 
-1.5 35.01 32.31 32.88 33.29 34.11 33.52 1.06 
-1 32.76 30.39 32.12 31.71 32.49 31.89 0.93 
-0.5 30.11 27.84 28.83 28.72 29.88 29.08 0.93 
0 31.92 30.45 29.29 31.18 31.82 30.93 1.09 
0.5 34.9 33.77 33.41 34.11 35.58 34.35 0.88 
1 33.89 32.81 33.68 33.17 34.66 33.64 0.71 
1.5 30.39 29.29 31.3 29.97 32.03 30.60 1.08 
2 25.92 25.6 25.85 25.51 26.41 25.86 0.35 
2.5 24.85 24.05 24.73 24.34 24.89 24.57 0.36 
3 23.75 22.86 23.04 23.29 23.73 23.33 0.40 
3.5 20.59 19.74 20.93 20.22 20.94 20.48 0.51 
4 18.07 17.75 18.07 18.03 18.05 17.99 0.14 
4.5 17.2 16.71 16.92 16.95 17.04 16.96 0.18 
5 15.88 15.46 16.21 15.58 15.97 15.82 0.30 
5.5 14.5 13.73 14.18 14.12 14.22 14.15 0.28 
6 13.59 13.14 13.37 13.34 13.47 13.38 0.17 
6.5 11.27 10.75 12 11.05 11.59 11.33 0.48 
 
 
 
 
 
 
 
 
 
 
Table A.11    Absorbed dose in horizontal profile in point Q, field A. 
          (film dosimetry). 
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Position 
cm 
M1 
cGy 
M2 
cGy 
M3 
cGy 
M4 
cGy 
M5 
cGy 
AVE 
cGy 
STD 
cGy 
-10.5 1.96 2.59 2.54 2.44 2.24 2.35 0.26 
-10 3.27 3.29 3.38 3.48 3.38 3.36 0.08 
-9.5 3.95 3.69 4 3.96 4.04 3.93 0.14 
-9 4.32 4.13 4.48 4.49 4.48 4.38 0.16 
-8.5 5.36 5.16 5.37 5.44 5.37 5.34 0.11 
-8 9.4 12.51 10.85 10.96 9.44 10.63 1.29 
-7.5 15.38 15.14 15.45 15.55 15.46 15.40 0.16 
-7 16.12 16 16.18 16.18 16.18 16.13 0.08 
-6.5 18.33 22.63 21.1 21.19 19.91 20.63 1.61 
-6 31.64 36.82 33.66 34.32 31.73 33.63 2.13 
-5.5 43.43 42.17 42.77 43.05 43.03 42.89 0.47 
-5 44.59 43.24 43.63 44.12 44.25 43.97 0.53 
-4.5 46.02 45.19 45.57 46.09 46 45.77 0.39 
-4 49.32 49.83 49.34 49.98 49.44 49.58 0.30 
-3.5 57.77 51.45 50.44 53.2 52.91 53.15 2.81 
-3 58.65 52.4 50.36 53.63 53.05 53.62 3.07 
-2.5 59.52 55.01 54.29 56.76 57.12 56.54 2.04 
-2 60.97 58.94 59.44 60.61 61.33 60.26 1.02 
-1.5 62.42 60.17 61.19 61.48 63.08 61.67 1.13 
-1 62.64 59.81 61.48 61.48 62.42 61.57 1.12 
-0.5 62.28 59.15 60.9 60.61 62.06 61.00 1.26 
0 49.61 46.86 47.8 47.63 48.4 48.06 1.03 
0.5 47.13 46.13 46.77 46.49 47.39 46.78 0.50 
1 47.01 46.09 46.68 46.58 47.43 46.76 0.50 
1.5 48.76 48.87 49.23 49.12 49.66 49.13 0.35 
2 52.11 53.71 55.67 53.27 56.61 54.27 1.83 
2.5 60.97 59.74 59.81 61.41 61.55 60.70 0.87 
3 63.73 57.7 59.01 61.41 61.84 60.74 2.39 
3.5 48.12 41.72 41.83 44.31 43.93 43.98 2.60 
 
 
 
 
 
 
 
 
 
 
Table A.12    Absorbed dose in vertical profile in point Q, field A. 
          (film dosimetry). 
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Position 
cm 
M1 
cGy 
M2 
cGy 
M3 
cGy 
M4 
cGy 
M5 
cGy 
AVE 
cGy 
STD 
cGy 
-2.5 11.35 13.02 9.44 5.6 16.42 11.17 4.03 
-2 24.57 23.16 24 21.9 24.48 23.62 1.11 
-1.5 25.88 25.6 25.62 25.01 27.04 25.83 0.75 
-1 29.03 26.06 27.85 28.26 28.33 27.91 1.12 
-0.5 34.17 31.67 32.69 30.11 33.82 32.49 1.66 
0 38.62 35.75 37.27 35.33 38.43 37.08 1.51 
0.5 42.21 39.84 41.17 39.5 41.72 40.89 1.18 
1 43.8 41.51 42.75 42.6 43.18 42.77 0.84 
1.5 44.05 41.68 42.68 43.37 43.39 43.03 0.90 
2 44.18 41.64 42.73 43.18 43.07 42.96 0.91 
2.5 41.79 38.56 40.7 42.6 40.44 40.82 1.53 
3 39.93 37.02 38.86 39.93 38.79 38.91 1.19 
3.5 37.29 33.59 36.27 38.21 34.9 36.05 1.85 
4 31.87 28.72 31.19 33.93 30.16 31.17 1.94 
4.5 28.42 25.47 27.29 29.51 26.95 27.53 1.53 
5 25.72 25.3 25.56 26.31 25.62 25.70 0.37 
5.5 24.3 22.93 23.91 25.14 23.71 24.00 0.81 
6 22.44 21.44 21.87 22.88 22.17 22.16 0.55 
6.5 21.94 21.33 21.76 21.62 22.47 21.82 0.42 
7 25.62 25.49 25.6 23.47 25.6 25.16 0.94 
7.5 25.62 25.19 25.62 25.62 25.62 25.53 0.19 
8 24.71 23.29 24.57 25.17 23.32 24.21 0.86 
8.5 13.79 12.6 14.67 18.08 11.44 14.12 2.53 
9 9.48 9.06 9.8 8.53 8.76 9.13 0.52 
9.5 7.55 7.2 7.93 6.78 6.79 7.25 0.50 
10 4.96 4.45 5.23 5.12 4.28 4.81 0.42 
10.5 3.66 3.45 3.82 3.75 3.45 3.63 0.17 
11 3.07 2.87 3.19 3.17 2.91 3.04 0.15 
11.5 2.57 2.36 2.74 2.65 2.36 2.54 0.17 
 
 
 
 
 
 
Table A.13   Absorbed dose in horizontal profile in point Q, field B. 
         (film dosimetry). 
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Position 
cm 
M1 
cGy 
M2 
cGy 
M3 
cGy 
M4 
cGy 
M5 
cGy 
AVE 
cGy 
STD 
cGy 
-10.5 10.21 10.6 9.6 10.86 11.9 10.63 0.85 
-10 33.56 32.69 33.02 28.83 35.13 32.65 2.33 
-9.5 36.91 35.48 35.9 33.24 37.85 35.88 1.74 
-9 40.01 38.21 39.48 38.83 39.84 39.27 0.75 
-8.5 37.55 35.56 36.55 36.76 36.78 36.64 0.71 
-8 35.22 32.63 34.17 35.86 34.34 34.44 1.22 
-7.5 34.36 31.99 33.27 36.18 33.75 33.91 1.54 
-7 38.71 36.33 37.96 40.35 37.91 38.25 1.46 
-6.5 42.58 39.75 41.61 43.22 41.72 41.78 1.31 
-6 43.88 41.74 42.66 43.39 43.22 42.98 0.82 
-5.5 44.07 41.64 42.68 43.41 43.22 43.00 0.91 
-5 42.73 39.95 41.68 42.64 41.57 41.71 1.12 
-4.5 41.44 38.53 40.33 41.94 40.52 40.55 1.31 
-4 41.34 38.62 40.16 41.68 40.42 40.44 1.20 
-3.5 41.21 37.98 40.12 41.81 40.14 40.25 1.46 
-3 39.33 35.82 38.64 39.58 37.7 38.21 1.52 
-2.5 36.22 32.45 35.11 37.25 33.59 34.92 1.94 
-2 34.15 30.82 33.04 35.54 31.99 33.11 1.84 
-1.5 31.42 28.4 30.89 32.9 29.04 30.53 1.82 
-1 28.74 25.58 27.89 29.29 26.7 27.64 1.51 
-0.5 27.55 25.62 25.99 27.27 25.6 26.41 0.93 
0 25.51 24.14 25.33 25.58 24.6 25.03 0.63 
0.5 24.44 22.72 23.91 24.73 23.29 23.82 0.82 
1 22.35 20.45 22.01 22.65 20.78 21.65 0.98 
1.5 21.19 19.33 20.87 21.73 19.63 20.55 1.03 
2 18.76 17.89 18.6 19.74 17.89 18.58 0.76 
2.5 18.07 17.46 18.08 18.47 17.36 17.89 0.47 
3 16.92 16.01 17.07 17.52 15.89 16.68 0.71 
3.5 17.53 16.67 17.53 17.94 16.53 17.24 0.61 
 
 
 
 
 
 
 
 
 
Table A.14   Absorbed dose in vertical profile in point Q, field B. 
         (film dosimetry). 
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Position 
cm 
M1 
cGy 
M2 
cGy 
M3 
cGy 
M4 
cGy 
M5 
cGy 
AVE 
cGy 
STD 
cGy 
-7.5 3.34 3.33 3.29 3.16 3.30 3.28 0.07 
-7 3.34 3.21 3.38 3.26 3.32 3.30 0.07 
-6.5 4.31 4.23 4.32 4.18 4.27 4.26 0.06 
-6 5.86 5.29 6.09 5.83 5.78 5.77 0.29 
-5.5 15.53 11.09 16.52 15.67 14.52 14.66 2.12 
-5 40.50 30.72 42.35 38.35 38.07 38.00 4.43 
-4.5 57.91 53.17 57.59 56.50 57.25 56.48 1.93 
-4 60.79 60.59 59.11 59.10 59.24 59.77 0.85 
-3.5 59.68 59.23 58.03 57.92 56.92 58.36 1.10 
-3 58.56 58.36 57.01 56.86 55.86 57.33 1.12 
-2.5 49.10 53.93 47.47 46.71 48.71 49.18 2.82 
-2 37.01 40.94 36.79 34.31 36.55 37.12 2.39 
-1.5 34.14 34.62 35.44 31.58 33.05 33.77 1.50 
-1 33.50 35.77 34.73 30.92 33.61 33.71 1.81 
-0.5 30.32 32.85 31.48 28.75 30.06 30.69 1.55 
0 30.17 32.10 31.63 29.29 29.76 30.59 1.22 
0.5 31.74 33.20 33.95 32.00 31.73 32.52 1.00 
1 31.56 33.81 33.87 32.48 31.91 32.72 1.07 
1.5 30.89 33.77 32.62 31.63 31.31 32.05 1.16 
2 28.51 31.14 29.84 28.90 28.34 29.35 1.16 
2.5 25.68 28.74 26.51 27.24 25.53 26.74 1.31 
3 24.19 26.40 24.92 26.59 23.43 25.11 1.37 
3.5 23.10 25.53 23.43 25.43 22.36 23.97 1.43 
4 20.03 22.25 20.29 22.20 19.02 20.76 1.42 
4.5 18.50 20.75 18.68 20.68 18.06 19.33 1.28 
5 16.00 17.79 16.13 18.18 16.55 16.93 0.99 
5.5 14.24 16.52 13.96 16.29 15.58 15.32 1.17 
6 11.01 13.39 10.96 13.07 12.69 12.22 1.16 
6.5 9.32 11.41 9.51 11.03 10.92 10.44 0.95 
Table A.15   Absorbed dose in horizontal profile in point Q, field A. 
            (Profiler dosimetry). 
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Position 
cm 
M1 
cGy 
M2 
cGy 
M3 
cGy 
M4 
cGy 
M5 
cGy 
AVE 
cGy 
STD 
cGy 
-10.5 2.66 2.73 2.64 2.68 2.59 2.66 0.05 
-10 3.36 3.48 3.33 3.43 3.29 3.38 0.08 
-9.5 3.03 3.13 3.00 3.07 2.94 3.04 0.07 
-9 3.53 3.63 3.50 3.52 3.41 3.52 0.08 
-8.5 4.19 4.17 4.14 3.92 3.89 4.06 0.15 
-8 12.03 12.40 11.93 11.53 11.46 11.87 0.39 
-7.5 13.82 14.61 13.63 13.96 13.49 13.90 0.43 
-7 16.70 17.27 16.41 16.31 16.17 16.58 0.44 
-6.5 28.15 27.95 26.81 25.07 27.49 27.09 1.24 
-6 39.40 39.34 37.89 35.74 39.12 38.30 1.55 
-5.5 41.57 41.79 39.92 38.83 41.74 40.77 1.33 
-5 43.38 43.61 41.75 40.75 43.55 42.61 1.29 
-4.5 45.55 44.45 43.82 42.50 45.25 44.31 1.22 
-4 54.50 53.91 52.89 50.86 52.85 53.00 1.39 
-3.5 55.13 54.88 53.45 51.93 53.45 53.77 1.29 
-3 55.81 55.44 54.24 52.56 54.13 54.44 1.28 
-2.5 58.25 57.67 56.47 55.18 56.62 56.84 1.19 
-2 60.16 59.84 58.51 58.11 58.57 59.04 0.90 
-1.5 60.79 60.59 59.11 59.10 59.24 59.77 0.85 
-1 60.40 60.14 58.64 58.71 58.89 59.36 0.85 
-0.5 58.22 58.03 56.20 57.14 57.21 57.36 0.81 
0 46.86 45.44 44.85 45.17 47.11 45.89 1.03 
0.5 46.01 44.27 44.05 43.79 46.19 44.86 1.14 
1 46.13 44.15 44.10 43.89 46.24 44.90 1.17 
1.5 51.56 47.94 47.79 49.47 49.78 49.31 1.54 
2 55.03 51.39 51.02 54.05 52.78 52.85 1.71 
2.5 60.32 57.78 56.49 58.15 56.94 57.94 1.49 
3 57.33 55.96 53.60 55.78 54.68 55.47 1.41 
3.5 40.62 40.38 38.15 38.59 39.81 39.51 1.09 
 
 
 
 
 
 
 
 
 
 
 
Table A.16   Absorbed dose in vertical profile in point Q. field A. 
 (Profiler dosimetry). 
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Position 
cm 
M1 
cGy 
M2 
cGy 
M3 
cGy 
M4 
cGy 
M5 
cGy 
AVE 
cGy 
STD 
cGy 
-2.5 8.04 6.06 7.53 8.86 8.36 7.77 1.07 
-2 24.40 21.80 24.74 24.34 24.23 23.90 1.19 
-1.5 28.77 27.54 29.59 28.65 28.55 28.62 0.73 
-1 30.48 29.70 31.85 30.26 30.19 30.50 0.81 
-0.5 33.12 31.44 34.04 33.01 32.65 32.85 0.94 
0 36.52 34.97 37.10 36.36 36.02 36.19 0.79 
0.5 39.63 38.04 38.89 39.39 39.04 39.00 0.61 
1 42.73 41.66 42.04 42.46 42.19 42.21 0.41 
1.5 42.73 42.03 42.20 42.41 42.20 42.31 0.27 
2 42.75 42.15 42.23 42.34 42.20 42.33 0.24 
2.5 40.82 41.05 40.42 40.11 40.10 40.50 0.43 
3 38.47 38.35 38.35 37.96 37.88 38.20 0.26 
3.5 36.45 36.57 37.41 35.60 35.61 36.33 0.76 
4 33.03 33.34 34.61 32.23 32.30 33.10 0.97 
4.5 30.75 30.67 32.26 30.26 30.26 30.84 0.83 
5 29.88 29.77 31.40 29.19 29.27 29.90 0.89 
5.5 26.50 25.66 27.90 25.86 25.83 26.35 0.93 
6 24.89 22.53 26.43 24.37 24.41 24.52 1.40 
6.5 24.69 21.42 26.34 24.64 24.12 24.24 1.79 
7 27.03 22.44 28.79 25.40 26.07 25.95 2.34 
7.5 28.74 25.34 30.76 25.61 27.22 27.53 2.26 
8 27.67 24.90 29.80 24.19 26.07 26.53 2.26 
8.5 20.48 20.69 23.44 16.83 19.78 20.24 2.36 
9 12.95 12.38 15.83 12.04 14.26 13.49 1.56 
9.5 10.71 10.33 13.29 9.75 11.90 11.20 1.41 
10 6.72 7.08 8.32 5.69 6.92 6.95 0.94 
10.5 4.17 3.99 4.50 3.71 4.11 4.10 0.29 
11 2.52 2.33 2.69 2.25 2.46 2.45 0.17 
11.5 2.05 1.89 2.12 1.81 1.98 1.97 0.12 
 
 
 
 
 
 
 
 
 
 
Table A.17   Absorbed dose in horizontal profile in point Q, field B. 
(Profiler dosimetry). 
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Position 
cm 
M1 
cGy 
M2 
cGy 
M3 
cGy 
M4 
cGy 
M5 
cGy 
AVE 
cGy 
STD 
cGy 
-10.5 8.30 8.00 6.35 7.25 7.23 7.42 0.76 
-10 32.45 32.07 29.47 31.10 31.00 31.22 1.16 
-9.5 36.42 36.06 35.41 35.70 35.58 35.83 0.40 
-9 39.79 39.35 39.21 39.44 39.31 39.42 0.22 
-8.5 37.38 36.91 37.17 37.11 36.99 37.11 0.18 
-8 35.82 35.32 35.60 35.57 35.45 35.55 0.19 
-7.5 34.49 33.89 33.92 34.03 33.92 34.05 0.25 
-7 37.46 36.78 36.64 36.89 36.77 36.91 0.32 
-6.5 40.71 40.00 39.87 40.19 40.06 40.17 0.33 
-6 42.63 42.02 42.01 42.17 42.03 42.18 0.26 
-5.5 42.75 42.15 42.23 42.34 42.20 42.33 0.24 
-5 42.19 41.51 41.93 41.89 41.75 41.85 0.25 
-4.5 40.04 39.33 39.70 39.64 39.51 39.65 0.26 
-4 39.76 39.01 39.33 39.32 39.19 39.32 0.28 
-3.5 39.61 38.80 39.20 39.25 39.12 39.19 0.29 
-3 38.62 37.92 38.50 38.42 38.29 38.35 0.27 
-2.5 36.69 35.89 36.62 36.60 36.48 36.46 0.33 
-2 34.17 33.27 34.01 34.02 33.91 33.88 0.35 
-1.5 33.48 32.62 33.38 33.37 33.26 33.22 0.34 
-1 31.35 30.52 31.22 31.27 31.17 31.11 0.33 
-0.5 29.81 29.11 29.56 29.54 29.45 29.49 0.25 
0 28.84 28.12 28.78 28.72 28.62 28.62 0.29 
0.5 26.37 25.48 26.34 26.29 26.20 26.14 0.37 
1 24.74 24.02 24.76 24.66 24.58 24.55 0.31 
1.5 23.09 22.29 22.99 22.97 22.90 22.85 0.32 
2 22.39 21.59 22.36 22.36 22.28 22.19 0.34 
2.5 20.42 19.43 20.31 20.33 20.26 20.15 0.41 
3 19.84 18.80 19.83 19.85 19.78 19.62 0.46 
3.5 17.11 15.92 16.86 16.90 16.85 16.73 0.46 
 
 
 
 
 
 
 
 
 
 
 
Table A.18   Absorbed dose in vertical profile in point Q, field B. 
(Profiler dosimetry). 
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Figure B.1  Horizontal profile, point P, field A  given by RIT113. 
Figure B.2  Vertical profile, point P, field A  given by RIT113.  
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Figure B.3  Horizontal profile, point P, field B  given by RIT113 . 
Figure B.4  Vertical profile, point P, field B  given by RIT113.  
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Figure B.5  Horizontal profile, point Q, field A  given by RIT113 . 
Figure B.6  Vertical profile, point Q, field A  given by RIT113.  
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Figure B.7  Horizontal profile, point Q, field B  given by RIT113.  
Figure B.8  Vertical profile, point Q, field B  given by RIT113 . 
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* 
Figure C.1     Map of dose for Field A.  The star indicates the point  
                       where the dose was measured. 
measurement. 
Figure C.2.  Isodose distribution, field A.  Taken from film  
                     dosimetry and RIT113 software. 
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Coordinate 
cm 
ADAC 
cGy 
Film 
cGy 
Profiler 
cGY 
-7.5 2.05 2.28 2.65 
-7 4.42 4.07 3.81 
-6.5 10.36 7.24 7.08 
-6 15.22 15.13 15.15 
-5.5 16.36 16.42 18.03 
-5 17.17 16.81 19.17 
-4.5 23.40 17.98 24.12 
-4 34.86 29.07 34.62 
-3.5 41.38 34.97 40.64 
-3 45.61 40.7 43.87 
-2.5 50.54 43.22 47.29 
-2 58.31 49.53 55.06 
-1.5 61.98 54.48 59.89 
-1 62.29 55.5 60.50 
-0.5 60.38 55.5 59.77 
0 52.15 51.87 55.11 
0.5 40.47 42.29 45.31 
1 32.55 34.1 37.00 
1.5 28.47 28.08 31.36 
2 27.34 25.46 30.09 
2.5 24.46 23.81 28.36 
3 16.71 19.65 22.29 
3.5 8.76 14.41 14.51 
4 3.44 8.21 6.76 
 
 
 
 
 
Table C.1.  Horizontal profile dose, field A. (ADAC, Film and Profiler). 
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Figure C.3.  Plot of horizontal profile, Field A. (Given by RIT113  
                     software, film dosimetry and ADAC ). 
Figure C.4.  Plot of the horizontal profile, field A.  The figure 
                     shows the plot given by ADAC, Film and Profiler. 
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Coordinate 
cm 
ADAC 
cGy 
Film 
cGy 
Profiler 
cGY 
-7 28.09 32.23 27.31822 
-6.5 37.69 34.64 37.1851 
-6 39.26 34.94 39.4407 
-5.5 39.86 34.7 40.03069 
-5 40.61 35.24 41.11926 
-4.5 43.79 39.46 43.57456 
-4 50.24 48.87 51.16356 
-3.5 56.74 53.32 57.36035 
-3 60.85 55.13 59.83656 
-2.5 61.98 55.46 60.5 
-2 61.72 55.83 60.46857 
-1.5 60.33 55.18 59.98684 
-1 57.16 53.19 59.1793 
-0.5 54.33 49.25 54.71834 
0 51.55 46.4 50.81279 
0.5 50.32 45.87 50.23799 
1 49.94 45.34 49.62391 
1.5 49.39 44.25 48.36962 
2 49.10 43.88 47.78008 
2.5 48.72 44.03 47.29403 
3 45.73 42.97 46.60352 
3.5 34.99 40.1 44.42969 
4 17.37 34.1 37.86896 
4.5 5.52 16.8 11.21777 
5 2.12   4.715449 
 
 
 
 
 
 
 
Table C.2.  Vertical profile dose, field A. (ADAC, Film and Profiler). 
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Figure C.5.  Vertical profile, Field A. (Given by RIT113 software). 
Figure C.6.  Plot of the vertical profile, field A.  The figure 
                     shows the plot given by ADAC, Film and Profiler. 
Vertical Profile, field A (ADAC, Film, Profiler)
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* 
Figure C.7     Map of dose for Field B.  The star indicates the point 
                      where the dose was measured . 
Measurement. 
Figure C.8.  Isodose distribution, field B.  Taken from film  
                     dosimetry and RIT113 software. 
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Coordinate 
cm 
ADAC 
cGy 
Film 
cGy 
Profiler 
cGy 
-6.5 1.56 1.01 2.24 
-6 2.01 2.25 3.35 
-5.5 2.41 2.67 2.84 
-5 2.84 3.27 3.59 
-4.5 4.02 4.23 4.22 
-4 13.07 6.22 6.68 
-3.5 32.11 11.99 15.49 
-3 49.16 24.23 37.49 
-2.5 53.18 48.85 49.10 
-2 50.72 49.93 50.14 
-1.5 46.09 49.93 48.32 
-1 43.90 46.53 44.59 
-0.5 43.31 45.47 44.31 
0 43.45 46.79 46.01 
0.5 43.49 47.99 47.77 
1 43.59 45.36 45.95 
1.5 44.09 43.17 46.05 
2 44.03 42.69 46.04 
2.5 42.26 41.8 44.77 
3 35.96 39.51 41.73 
3.5 22.62 32.77 28.43 
4 7.91 11.9 10.16 
4.5 2.48 5.93 5.71 
5 1.23 2.3 4.04 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table C.3.  Horizontal profile dose, field B.(ADAC, Film and Profiler ). 
 101 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure C.9.  Horizontal profile, Field B. (Given by RIT113 software). 
Figure C.10.  Plot  of the horizontal profile, field B.  The figure  
                      shows the plot given by ADAC, Film and Profiler. 
Horizontal Profile, field B (ADAC, Film, Profiler )
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Coordinate 
cm 
ADAC 
cGy 
Film 
cGy 
Profiler 
cGy 
-7 27.01 7.75 13.95 
-6.5 37.05 31.93 32.30 
-6 39.44 34.64 35.34 
-5.5 39.85 35.64 37.15 
-5 38.30 35.8 37.51 
-4.5 35.68 34.7 35.04 
-4 34.23 33.47 32.78 
-3.5 34.43 32.68 32.66 
-3 35.52 32.71 32.84 
-2.5 36.54 34.37 34.33 
-2 39.20 35 35.46 
-1.5 44.26 37.21 38.60 
-1 50.29 42.51 44.27 
-0.5 53.18 49.31 48.53 
0 53.55 49.78 49.10 
0.5 53.40 49.71 48.88 
1 53.27 49.42 48.55 
1.5 52.97 49.49 48.48 
2 52.05 49.02 48.06 
2.5 49.18 48.67 46.85 
3 40.83 45.73 42.04 
3.5 25.66 35.62 31.87 
4 9.35 21.94 14.81 
4.5 2.78 7.15 5.82 
Table C.4.  Vertical profile dose, field B. (ADAC, Film and Profiler). 
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Figure C.11.  Vertical profile, Field B. (Given by RIT113 software). 
Figure C.12.  Plot of the vertical profile, field B.  The figure  
                       shows the plot given by ADAC, Film and Profiler. 
Vertical Profile, field B (ADAC, Film, 
Profiler)
0.00
20.00
40.00
60.00
-10 -5 0 5 10
cm
d
o
se
 (c
G
y)
ADAC
FILM
PROFILER
 104 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* 
Figure C.13     Map of dose for Field C.  The star indicates the point  
                        where the dose was measured . 
Measurement. 
Figure C.14.  Isodose distribution, field C.  Taken from film  
                       dosimetry and RIT113 software. 
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Coordinate 
cm 
ADAC 
cGy 
Film 
cGy 
Profiler 
cGy 
-7.5 4.21 4.83 3.90 
-7 7.29 9.7 5.88 
-6.5 8.50 10.54 8.41 
-6 8.49 10.82 9.28 
-5.5 8.83 11.53 9.56 
-5 10.63 13.26 10.60 
-4.5 15.38 17.53 15.63 
-4 21.96 22.12 22.97 
-3.5 25.61 24.23 26.84 
-3 29.16 30.55 29.13 
-2.5 34.92 34.64 34.88 
-2 40.95 42.29 40.44 
-1.5 45.27 46.29 44.11 
-1 46.96 46.77 44.62 
-0.5 47.95 47.7 45.56 
0 51.56 52.71 48.75 
0.5 55.59 52.98 52.81 
1 55.82 52.78 52.78 
1.5 53.01 51.37 50.23 
2 43.69 38.78 45.93 
2.5 31.08 28.8 36.44 
3 22.65 21.34 27.96 
3.5 16.59 16.57 21.21 
4 8.58 8.66 14.90 
4.5 3.10 4.26 6.63 
 
 
 
 
 
 
 
 
 
 
 
Table C.5.  Horizontal profile dose, field C. (ADAC, Film and Profiler). 
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Figure C.15.  Horizontal Profile, Field C. (Given by RIT113 software). 
Figure C.16.  Plot of the horizontal profile, field C.  The figure  
                        shows the plot given by ADAC, Film and Profiler. 
Horizontal Profile, field C (ADAC, Film, Profiler )
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Coordinate 
cm 
ADAC 
cGy 
Film 
cGy 
Profiler 
cGy 
-7 6.25 6.22 5.35 
-6.5 18.21 14.98 13.39 
-6 25.72 17.86 17.98 
-5.5 28.00 24.98 26.61 
-5 29.43 27.36 28.12 
-4.5 32.38 30.97 30.56 
-4 40.23 39.33 38.29 
-3.5 50.43 52.27 50.59 
-3 55.59 53.65 52.78 
-2.5 55.85 53.74 52.79 
-2 52.66 52.18 50.45 
-1.5 47.58 45.87 43.27 
-1 43.03 41.49 38.92 
-0.5 40.08 37.74 36.09 
0 38.90 37.03 35.85 
0.5 38.60 35.64 34.62 
1 38.55 35.93 34.91 
1.5 38.43 35.8 34.81 
2 38.33 35.44 34.24 
2.5 37.82 34.82 33.74 
3 36.26 34.85 32.76 
3.5 32.67 32.23 30.24 
4 23.01 22.57 22.66 
4.5 8.05 7.06 5.76 
 
 
 
 
 
 
 
 
 
 
 
Table C.6.  Vertical profile dose, field C. (ADAC, Film and Profiler). 
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Figure C.17.  Vertical profile, Field C. (Given by RIT113 software). 
Figure C.18.  Plot of vertical profile, field C.  The figure shows 
                       the plot given by ADAC, Film and Profiler. 
Vertical Profile, field C (ADAC, Film, 
Profiler)
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Figure C.19     Map of dose for Field D.  The star indicates the point  
                         where the dose was measured. 
Measurement. 
* 
Figure C.20.  Isodose distribution, field D.  Taken from film 
                       dosimetry and RIT113 software. 
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Coordinate 
cm 
ADAC 
cGy 
Film 
cGy 
Profiler 
cGy 
-7.5 1.25 0.96 1.53 
-7 1.94 2.43 1.92 
-6.5 2.27 3.03 2.64 
-6 2.71 3.89 3.98 
-5.5 5.12 5.97 5.53 
-5 12.84 14.08 9.29 
-4.5 25.91 25.43 21.47 
-4 41.33 39.51 37.85 
-3.5 50.93 50.55 51.11 
-3 54.46 52.73 56.21 
-2.5 54.40 53 57.09 
-2 50.61 52.71 57.02 
-1.5 42.83 48.83 52.64 
-1 38.24 38.11 43.08 
-0.5 37.60 36.13 40.66 
0 37.86 36.88 39.89 
0.5 40.80 41.01 41.14 
1 46.30 45 42.44 
1.5 51.65 47.66 43.48 
2 56.30 53.88 49.81 
2.5 57.36 56.01 53.75 
3 54.70 55.04 53.80 
3.5 46.08 52.18 51.53 
4 33.87 39.15 40.72 
4.5 25.80 29.04 32.03 
5 13.47 19.99 24.36 
5.5 2.19 7.1 8.16 
6 0.00 4.14 5.03 
 
 
 
 
 
 
 
 
Table C.7.  Horizontal profile dose, field D. (ADAC, Film and Profiler). 
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Figure C.21.  Horizontal profile, Field D. (Given by RIT113 software). 
Figure C.22.  Plot of horizontal profile, field D.  The figure 
                       shows the plot given by ADAC, Film and Profiler. 
Horizontal Profile, field D (ADAC, Film, Profiler )
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Coordinate 
cm 
ADAC 
cGy 
Film 
cGy 
Profiler 
cGy 
-7 7.08 9.59 8.91 
-6.5 20.15 25.01 27.65 
-6 28.13 27.9 30.23 
-5.5 30.16 30.25 31.32 
-5 31.06 31 31.78 
-4.5 33.18 32.65 33.30 
-4 40.96 39.28 39.57 
-3.5 52.20 52.8 48.12 
-3 57.36 55.27 53.80 
-2.5 58.02 54.9 54.19 
-2 56.55 54.16 52.92 
-1.5 51.83 51.7 47.21 
-1 44.38 41.32 39.92 
-0.5 39.65 36.86 37.86 
0 37.59 35.31 36.40 
0.5 36.71 34.88 35.17 
1 36.25 34.88 34.31 
1.5 35.47 34.58 32.45 
2 34.09 32.23 30.56 
2.5 32.41 31 28.41 
3 27.79 26.21 21.38 
3.5 17.58 15.04 10.74 
4 6.96 5.52 4.82 
 
 
 
 
 
 
 
 
 
 
Table C.8.  Vertical profile dose, field D. (ADAC, Film and Profiler ). 
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Figure C.23.  Vertical profile, Field D. (Given by RIT113 software). 
Figure C.24.  Plot of vertical profile, field D.  The figure shows 
                       the plot given by ADAC, Film and Profiler. 
Vertical Profile, field D (ADAC, Film, 
Profiler)
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HOW TO CONVERT ADAC FILES TO TXT FILES 
 
a) Open the RIT113 software; 
b)  Click on [FILE] ; 
 
 
c) Scroll down and click in [PINNACLE DOSE GRID IMPORT]; 
Enter the ADAC dose grid file name [HEADER or HEA]; 
 
 
 
 
Figure D.1  RIT113  menu 
Figure D.2   Dose Grid Read Window 
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d) press [OK]; 
e) The image of the ADAC file will appear. Press [OK]; 
f) The image will disappear but it will be posted in the image stack window; 
 
 
 
 
 
g) Left click in the image name in the image stack window; 
h) Browse down and click [SAVE AS]; 
i) a window “Save Image As…” will appear (see Figure D.4); 
File name:    name of the file 
List file of Type: ASCII (*.TXT) 
  Directories:  Choose the directory where the file will be saved. 
 
Figure D.3    Image Stack Window 
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                   and 
 
j) The ADAC file has been saved as TXT file and is ready to be used. If the 
header file was recorded with a pixel size of 5x5 mm, a average of the dose 
rate for every 5x5 mm will be display in the TXT file. When the TXT file is 
pulled from Excel, each value will be placed in a single cell. 
 
 
HOW TO CONVERT A FILM PROFILE DATA TO TXT FILE 
a) Click [DOSE] in main menu.  (see Figure D.1); 
b) Scroll down the DOSE menu and click [CROSS SECTION PROFILE]; 
c) The window in Figure D.5 will appear.  Enter the image file name that you 
want to make a profile of and the respectively calibration film file. The other 
data can be omitted; 
d) Click [OK]; 
Figure D.4  Save Image window 
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e) The image of the scanned film will appear. Press [CONTINUE]; 
f) The window in Figure D.6 will appear. The window is asking for the region of 
interest (ROI); 
 
 
 
 
 
 
g) Choose YES and press [OK]; 
h) The window in Figure D.7 will appear.  The window is asking for alignment 
method or rotation and filter type. Choose NONE alignment method and 5x5 
MEDIAN  filter; 
Figure D.5  Cross section profile analysis window 
Figure D.6   Window ROI 
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i) Press [OK]; 
j) Press [CONTINUE] to the window that will appear next. It explains some 
instruction to get the profile data; 
k) The window in Figure D.8 will appear. Choose USER and press [OK]; 
 
 
l) The image of the film will appear and a “Multi-Line extract” window (Figure 
D.9) as well. Choose a line (horizontal or vertical) and place it in the point in the 
image that you want to have the profile.  Press [ACCEPT]; 
m) “Rit Cross Section Analysis” window will appear next. (Figure D.10); 
 
 
Figure D.7 Image Modification window 
Figure D.8  Cross section window 
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n) In Y-axis in Percent or Dose question choose DOSE, flatness and symmetry 
choose Varian, Penumbra Low (20) and Penumbra High (80); 
o) The image of the profile will appear. Press [CONTINUE]; 
p) Window in Figure D.11 will appear. Press [OK]; 
 
Figure D.9   Multi- line extract window 
Figure D.10  Cross section analysis window 
Figure D.11   Window for number of time to filter 
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q) Window in Figure D.12 will appear next. Print and save this plot choose NO 
unless you want otherwise. In type of image to save choose ASCII. Press [OK]; 
 
r) Enter the desired dose format. (Figure D.13). Press [OK]. The following window will 
be Figure D.14. Enter the output file name and the distance increment of 5 mm; and 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure D.13  ASCII output window 
Figure D.14  ASCII output window 
Figure D.12   Image Archive window 
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s) Finally, RIT113 will ask you if you want to re-analyze the image. If you choose 
YES, repeat the procedure from step j. 
 
 
 
 
If you want additional information about each step, please read the RIT113 software 
user’s manual. It is always near to the RIT113 computer. 
 
HOW TO CONVERT PROFILER FILES TO TXT FILES 
 
 Files saved in profiler software have extension .pro and obviously they can be 
opened only with profiler software. However, every time that data is saved with profiler, 
a TXT file containing all the data collected (see manual for details [6]) is created 
automatically.  This file can be opened by other programs like Excel. 
 
HOW TO LOAD TXT FILES IN EXCEL 
Obviously, the data collected by film dosimetry, profiler and ADAC need to be analyzed 
and the best way is by using a spreadsheet such as Excel. In this project Excel was the 
spreadsheet used to analyze the data: 
a) open Excel; 
b) On the main menu click [DATA]. See Figure D.16; 
Figure D.15  Window asking to re-analyze image 
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c) Scroll down the DATA menu and click [Import External Data], [Import 
Data….]; 
d) A browser window will appear. Look for the TXT file that you want to paste 
in the spreadsheet. Click [OPEN]; 
e) The wizard will determine that your data is delimited. Click next and choose 
TAB & SPACE as delimiters. See Figure D.17; 
 
 
 
 
 
 
 
 
 
 
Figure D.16  Excel main menu 
Figure D.17  Text Import Wizard 
 124 
 
f) Click [finish].  You will be asked in what cell you want to put the data. Figure 
D.18; and 
 
 
 
 
 
 
 
 
g) Click [OK] and your data will be pasted in the worksheet. 
 
Having all the data in the worksheet, any operation can be done with them.  
Data collected in TXT files from film are already expressed in dose (cGy).  Data 
collected in TXT files from ADAC are expressed in dose rate (cGy/MU). It needs to be 
multiplied by the monitor units used to obtain Dose (cGy).  
 On the other hand, the data collected in TXT files from profiler contains a various 
parameters like, temperature, time, duration of radiation time, row data, calibration 
factors, “K” factor, file name, etc. However, it is easy to get familiar with it because 
every value will always be placed in the same cell. The calibration factors for each 
detector, for instance, will be placed in cells H12 to BA12.  H11 to BA11 contain the 
detector number (from 1 to 46).  From H15 to BA15, the raw data collected by each 
Figure D.18  Import Data Window 
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detector will be placed.  To convert the collected data into Dose (cGy), the following step 
are followed; 
a) Cells (H12..BA12) contains the array calibration factor.  Data collected by 
every detector needs to be corrected by its respectively calibration factor. 
Cells (H15-BA15) contains the raw data collected by each detector so each 
value in row 12 is multiplied by its respectively value in row 15 ( from H  to 
BA column); 
b) The new values calculated are now normalized to the average of the two 
central detectors. The two central diodes are 23 an 24 which are placed in AD 
and AE columns.  
2423
2
DD
D
D iNi +
=      (D.1) 
 where  NiD  is the normalized value in detector i ;  and 
 
c) Finally, multiply NiD   by the dose shown in the profiler display.  
layofilerDisp
N
iiector cGyDDD Pr)(det )(*=   (D.2) 
  Where Ddetector(i) will be the dose measured y detector i. 
 
Remember, the dose given in the profiler display is the average dose measured by 
the two central diodes. This value needs to be written manually in order to appear in 
the TXT file.  When saving the data collected by the profiler, a window for profile 
header information will appear (see Figure D.19). Write the dose shown in the 
 126 
profiler display in the dose space (see Figure D.19).  When open the TXT file this 
value will appear in cell E43. 
 
 
 
 Once all the TXT files are in the worksheet, analysis of the data can be done. 
Certainly, several instructions need to be performed to obtain the comparison that we 
want. However, all these instruction (including extracting the data from the TXT files) 
can be stored in an Excel macro to do the process faster every time we need to analyze 
the data. In that way, all the analysis (graphs, tables, doses) can be obtained by just 
clicking a single key. 
 
 
Figure D.19 Window for profiler header information 
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